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ABSTRACT 
 
Bee-collected pollen has been used as a folk medicine and foodstuff for human 
consumption for centuries. Even today it is very sought after for its therapeutic and 
nutritional properties.  
On the other hand, several classes of bee pollen components have been used to 
establish quality parameters of pollen, to characterize it in terms of botanical origin, to 
recognize taxonomic markers and to evaluate their nutritional and biological properties. 
Oxidative stress and inflammation play important roles in disease development. This 
dissertation intended to evaluate the anti-inflammatory and anti-allergic potential of 
Echium plantagineum L. bee pollen to support its claimed health beneficial effects. 
The hydromethanol extract efficiently scavenged nitric oxide radical (NO), although 
against superoxide anion (O2
-) it behaved as antioxidant at lower concentrations and as 
pro-oxidant at higher concentrations. The anti-inflammatory potential was evaluated in 
LPS-stimulated macrophages. The levels of NO and L-citrulline decreased for all extract 
concentrations tested, while the levels of prostaglandins, their metabolites and 
isoprostanes, evaluated by UPLC-MS, decreased with low extract concentrations. So, E. 
plantagineum bee pollen can exert anti-inflammatory activity by reducing NO and 
prostaglandins.  
The anti-allergic potential of the hydromethanol extract obtained from E. plantagineum 
bee pollen was also evaluated, by assessing β-hexosaminidase release in rat basophilic 
leukemic cells (RBL-2H3). Two different stimuli were used: calcium ionophore A23187 
and IgE/antigen complex. Lipoxygenase inhibitory activity was evaluated in a cell-free 
system. 
In RBL-2H3 cells stimulated with calcium ionophore or IgE/antigen, the hydromethanol 
extract significantly decreased β-hexosaminidase release until the concentration of 2.08 
mg mL-1, without compromising cellular viability. No effect was found on lipoxygenase. 
Overall, this study showed promising results, substantiating for the first time the utility of 
the intake of E. plantagineum bee pollen to prevent allergy and ameliorate allergy 
symptoms, although a potentiation of an allergic response can occur, depending on the 
dose used. 
The hydromethanol extract was analysed for its phenolic content, as it is known that 
these are important bioactive compounds. The chromatogram obtained by HPLC-DAD 
showed kaempferol-3-O-neohesperidoside as a major peak, followed by its acylated 
derivative, kaempferol-3-O-(3’/4’-acetyl)-neohesperidoside, and eight minor peaks 
Abstract 
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corresponding to quercetin and kaempferol derivatives. In addition, HPLC-UV and GC-
IT/MS methods were used to determine organic acids and fatty acids, respectively. Eight  
organic acids and five fatty acids were determined for the first time, malonic acid and α-
linolenic acid being the main compounds from each class. This extract revealed to be 
devoid of alkaloids. 
To widen the knowledge in E. plantagineum bee pollen, two fractions of pollen’s 
acidified methanol extract, enriched either in flavonols or anthocyanins, were 
characterized by HPLC-DAD and their antioxidant properties were evaluated in Caco-2 
cells subjected to oxidative stress induced by tert-butyl hydroperoxide (t-BHP). For 
comparison purposes the whole extract was also studied. 
Seven flavonols and five anthocyanins were detected in both whole extract and fraction 
II, while fraction I contained six flavonols (in higher amounts than in fraction II) and small 
amounts of petunidin-3-O-rutinoside. The pre-exposition to fraction I imparted a tendency 
to protect cells, while fraction II and the whole extract aggravated the toxicity of t-BHP at 
some of the tested concentrations. 
The protective effects appeared to be correlated with the levels of total glutathione, 
while there was no observable correlation between cellular viability and reactive species. 
No significant effect on antioxidant enzymes activity was noticed. Overall, anthocyanins 
seemed to abrogate the antioxidant potential of flavonoid-rich E. plantagineum bee pollen 
extract. 
E. plantagineum bee pollen proved to be nutritionally and pharmacologically 
interesting, due to its chemical composition and to the biological activity of its constituents, 
namely phenolic compounds. This study contributes to increase the possibility of 
commercialization of this natural product in the granular form or as an extract. 
 
Keywords: Echium plantagineum L. bee pollen; metabolic profile; inflammation; allergy; 
oxidative stress. 
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RESUMO 
 
O pólen de abelha tem sido usado há séculos como remédio tradicional e alimento 
para consumo humano. Ainda hoje é muito procurado pelas suas propriedades nutritivas 
e terapêuticas. 
Por outro lado, várias classes de compostos do pólen de abelha têm sido utilizadas 
para se estabelecer os seus parâmetros de qualidade, para a sua caracterização em 
termos de origem botânica, reconhecimento de marcadores taxonómicos e avaliar as 
suas propriedades biológicas e nutricionais. 
A inflamação e o stress oxidativo desempenham um papel importante no 
desenvolvimento de várias doenças. Nesta dissertação pretendeu-se avaliar o potencial 
anti-inflamatório e antialérgico do pólen de abelha de Echium plantagineum L., para 
suporte científico dos seus aclamados efeitos benéficos para a saúde. 
O extrato hidrometanólico demonstrou capacidade para sequestrar o óxido nítrico 
(•NO); no entanto, relativamente ao radical anião superóxido (O2
•-) comporta-se como 
antioxidante em baixas concentrações e como pró-oxidante em concentrações mais altas. 
O potencial anti-inflamatório foi avaliado em macrófagos estimulados com LPS. Os níveis 
de •NO e de L-citrulina diminuíram com todas as concentrações de extrato testadas, 
enquanto os níveis de prostaglandinas, os seus metabolitos e isoprostanos, analisados 
por UPLC-MS, diminuíram com baixas concentrações de extrato. Assim, o extrato de 
pólen de abelha de E. plantagineum exerce atividade anti-inflamatória reduzindo os níveis 
de •NO e de prostaglandinas. 
O potencial anti-alérgico do extrato hidrometanólico de pólen de abelha de E. 
plantagineum foi, também testado relativamente ao seu efeito sobre a libertação de β-
hexosaminidase, em basófilos leucémicos de ratinho (RBL-2H3). Foram usados dois 
estímulos diferentes: o ionóforo de cálcio A23187 e o complexo IgE/antigénio. A atividade 
inibitória da lipoxigenase foi analisada em sistema não celular. 
O extrato hidrometanólico diminuiu significativamente a libertação de β-
hexosaminidase das células RBL-2H3 estimuladas com ionóforo de cálcio ou 
IgE/antigénio até à concentração de 2,08 mg mL-1, sem comprometer a viabilidade 
celular. Não foi observado qualquer efeito na lipoxigenase. Globalmente, foram obtidos 
resultados promissores que substanciam, pela primeira vez, a utilidade do consumo de 
pólen de abelha de E. plantagineum para prevenir a alergia e melhorar sintomas de 
alergia, apesar de poder ocorrer uma potenciação da resposta alérgica, dependendo da 
dose usada. 
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O extrato hidrometanólico foi analisado relativamente à sua composição fenólica. O 
cromatograma obtido por HPLC-DAD mostrou o canferol-3-O-neoesperidósido como 
composto principal, seguido de um seu derivado acilado, canferol-3-O-(3’/4’-acetil)-neo-
hesperidósido, além de oito compostos em menor quantidade, correspondentes a 
derivados de quercetina e de canferol. Adicionalmente, o extrato foi analisado por HPLC-
UV e por GC-IT/MS para pesquisa de ácidos orgânicos e de ácidos gordos, 
respetivamente. Oito ácidos orgânicos e cinco ácidos gordos foram determinados pela 
primeira vez, sendo o ácido malónico e o ácido α-linolénico os compostos principais de 
cada classe. Este extrato não apresentou alcaloides na sua composição. 
Para alargar o conhecimento do pólen de abelha de E. plantagineum foram 
caracterizadas por HPLC-DAD duas frações do extrato metanólico adicificado, ricas em 
flavonóis ou em antocianinas, cuja capacidade antioxidante foi avaliada em células Caco-
2 sob stress oxidativo induzido pelo terc-butil-hidroperóxido (t-BHP). O extrato inteiro foi 
usado para comparação. 
Na fração II e no extrato total foram identificados sete flavonóis e cinco antocianinas, 
enquanto a fração I continha seis flavonóis (em concentração superior à da fração II) e 
pequenas quantidades de petunidina-3-O-rutinósido. Da pré-exposição à fração I foi 
possível observar uma tendência para proteger as células, enquanto a fração II e o 
extrato total agravaram a toxicidade do t-BHP em algumas das concentrações testadas. 
Os efeitos protetores pareceram estar correlacionados com os níveis de glutationa 
total, não se tendo observado qualquer correlação entre a viabilidade celular e as 
espécies reativas. Os extratos não demonstraram ter efeito significativo na atividade das 
enzimas antioxidantes. Em geral, as antocianinas pareceram anular o potencial 
antioxidante do extrato metanólico acidificado do E. plantagineum rico em flavonóis.  
O pólen de abelha do E. plantagineum revelou ser interessante sob o ponto de vista 
nutricional e farmacológico, devido à sua composição química e à atividade biológica dos 
seus constituintes, principalmente dos seus compostos fenólicos. Este estudo contribui 
para aumentar a possibilidade de comercialização deste produto natural, na forma de 
granulado ou como um extrato. 
 
Palavras–chave: Pólen de abelha de Echium plantagienum L; perfil metabólico; 
inflamação; alergia; stress oxidativo. 
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LPS Lipopolysaccharide 
LT Leukotriene 
LX Lipoxin 
MHA Mueller Hinton agar 
MHB Mueller Hinton broth 
MIC Minimum inhibitory concentration 
MLC Minimum lethal concentration 
MS Mass spectrometry 
MSTFA N-methyl-N-(trimethylsilyl)trifluoroacetamide 
MTT (4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
NADH Nicotinamide adenine dinucleotide reduced form 
NBT Nitroblue tetrazolium 
•NO Nitric oxide radical 
OA Oleic acid 
O2
- Superoxide anion radical 
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PA Pyrrolizidine alkaloid 
PAL Phenylalanine ammonia-lyase 
PALMs Pollen-associated lipid mediators 
PANO Pyrrolizidine N-oxides 
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PG Prostaglandin 
PLA2 Phospholipase A2 
PMS Phenazine methosulfate 
PUFA Polyunsaturated fatty acid 
RP-C18 Reversed-phase C18 column 
RP-HPLC Reversed-phase high-performance liquid chromatography 
Rt Retention time 
SDA Stearidonic acid 
SNP Sodium nitroprusside 
SPE Solid-phase extraction 
tert-BHP tert-Butylhydroperoxide 
THF Tetra-hydrofuran 
TNB 5-thio-2-nitrobenzoic acid 
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UPLC Ultra performance liquid chromatography 
UPLC-QqQ-MS/MS Ultra performance liquid chromatography coupled with mass 
spectrometry 
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DISSERTATION OUTLINE 
 
The present dissertation is divided into five main sections: 
 
 
Chapter I – Introduction 
 
In chapter I a general overview on the thesis subject and objectives is included. A 
review on the existing literature about the different topics approached in this dissertation is 
provided. It affords a basis to understand the objectives and the obtained results. 
 
 
Chapter II – Experimental section 
 
This section provides detailed information about all the methods and techniques used 
for the realization of all the works presented in this dissertation. 
 
 
Chapter III – Results and discussion 
 
This section is divided in two main parts. The first part is related with the studies 
conducted with Echium plantagineum L. bee pollen hydromethanolic extract, namely the 
evaluation of its anti-inflammatory and anti-allergic potentials. The second one concerns 
to the study of the acidified methanol extract of the same matrix, relating its composition 
and the protective effect against oxidative stress. All of the results are integrated and 
discussed concerning their relevance, linking them to the existing scientific reports. 
 
 
Chapter IV – Conclusions and perspectives 
 
 
The main conclusions that can be taken from the developed work are summarized in 
this section. In addition, some future perspectives are approached. 
 
 
Chapter V – References 
 
 
In this last section are listed all the bibliographic references used in this dissertation.
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1. Echium plantagineum Linnaeus 
 
1.1. General considerations 
 
According to the “Taxonomic Nomenclature Checker Germplasm Resources 
Information Network” (TNC-GRIN), the Echium genus comprises twenty-four species. 
Other taxonomic databases, namely from the “International Association for Plant 
Taxonomy” (IAPT), the “International Plant Names Index” (IPNI) and the “International 
Global Plant Checklist” (IOPI) describe a long list of Echium species. 
The Echium genus (Boraginaceae) contains two distinctive nodes: the predominantly 
woody species of the macaronesian archipelago, and the herbaceous species that are 
chiefly distributed in Europe and North Africa (1). Within the latter group, the main centres 
of species diversity are the Iberian Peninsula, with about sixteen species, and North-West 
Africa (particularly Morocco) presenting about twenty species (1). 
In this dissertation Echium plantagineum L. was considered, which characteristics are 
provided below. 
 
1.2. Characteristics 
 
1.2.1. Habitat 
 
E. plantagineum is a widespread weed in warm-temperate regions. It is found mostly in 
areas dominated by winter rainfalls and can flourish in a wide range of soils (2). Native 
from western Mediterranean Basin, it extends into central Europe and locally naturalized 
in northern Europe (1). 
Since its introduction in Australia, E. plantagineum has spread to infest vast areas of 
predominantly agricultural land in south-east and south-west Australia, where it can be the 
dominant pasture species (3). 
 
1.2.2. Stems and leaves 
 
E. plantagineum is an annual herb, occasionally biennial, that grows to 1.5 m high, but 
commonly 30 to 60 cm. It is an erect softly hairy species, with several flowering stems, 
that reproduces by seed (1, 3). Young plants form rosettes with basal leaves that can be 
up to 25 cm long, broadly ovate, petiolate, with prominent lateral veins. As it grows, it 
produces several stems starting at the base of the plant, although it can occasionally be 
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found to be single stemmed. The stems have stout white hairs. The stem leaves are 
narrower and smaller, sessile and cordate at the base (2, 4).  
 
1.2.3. Flowers and fruit 
 
The inflorescence (Figure 1) is usually branched. The calyx is 7-10 mm at anthesis, up 
to 15 mm in the fruit. The corolla is 18-30 mm, trumpet shaped, curled and purple, and 
unrolls as the flowers open; it is hairy only on the veins and margins, usually with two or 
less exserted stamens (2, 4). The flowers are sessile, each one consisting of five petals 
that are 2-3 cm long and five stamens, two being longer than the others and projecting 
significantly from the corolla. Its filaments are rather sparsely hairy and the pollen is bluish 
(2). The fruit consists of four nutlets 2.5 x 2 mm, tuberculate, pale brownish-grey, 
surrounded by persistent stiffly bristled calyx (2, 4). 
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Figure 1. Several aspects of Echium plantagineum plant: A – Corolla with five stamens 
and one stigma, five petals; B – Stem with stout white hairs; C – Purple colour of the 
corolla, two stamens protruding, hence the common name “Purple Viper’s Bugloss”; D – 
Alternate flowers; E – Hairy leaf without petiole; F – Flowers in three stages of 
development; G – Pollen with the characteristic blue colour; H – Pollen´s microscopic 
analysis. 
(Photographs by Eduarda Moita, António Moita and Sérgio Moreira, Paredes de Coura, 
June 2011 and July 2014; different magnifications). 
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1.3. Distribution of E. plantagineum in Portugal 
 
E. plantagineum has a general distribution in the country, except in Alentejo coast 
(Serra do Cercal) and in Serra Algarvia (Serra de Monchique and Serra Espinhaço de 
Cão). It concentrates mainly in Alto Alentejo (Évora region) (Figure 2). In Portugal it is 
known as “Chupa-mel”, “Língua-de-vaca”, “Soagem” or “Soagem viperina”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Geographical distribution of E. plantagineum in Portugal [data from (5)]. 
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The habitat includes cultivated and ruderal areas, the budding season occurring in 
March-June. It is a therophyte and hemicryptophyte plant (4). 
 
2. Secondary metabolism 
 
Plants have the ability to synthesize an enormous variety of secondary metabolites, 
since they need to respond to a continuously changing and often hostile environment, in 
order to survive and reproduce (6). 
 
Environmental factors, such as nutrient supply, temperature, light conditions or 
atmospheric CO2 concentrations, can influence the levels of carbon-based secondary 
metabolites in plant tissues and plant partitioning of carbohydrates and energy. As it is 
generally known that secondary metabolism is linked to primary metabolism by the rates 
at which the substrates are diverted from primary pathways and funnelled into secondary 
biosynthetic routes, several environmental factors affecting growth, photosynthesis and 
other parts of primary metabolism will also affect secondary metabolism (7). 
 
2.1. Alkaloids 
 
Alkaloids are one of the most diverse classes of secondary metabolites found in living 
organisms, including a wide range of structures resulting from several biosynthetic 
pathways and with an array of pharmacological activities. Evidence suggests that they 
may serve specific biological functions. In some plants, the concentration of alkaloids 
increases just prior to seed formation and then drops off when the seed is ripe, suggesting 
that alkaloids may play a role in this process. Alkaloids may also protect some plants from 
destruction by certain insect species (8). 
 
Alkaloids are found in nature in the form of salts (citrates and malates), or combined 
with tannins (8). In plants they are part of the cell wall (8). They are basic, nitrogenated 
compounds, with nitrogen atom as part of a heterocyclic system, biosynthesis starting in 
an amino acid. In Table 1 are indicated the amino acids that are precursors of alkaloids 
and the characteristic nuclei they originate (8). 
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Table 1. Precursor amino acids and origin of the main alkaloid heterocycles. 
Precursor amino acid/origin                         Heterocycle 
Anthranilic acid  Quinoline, quinazoline, benzoxazine 
Nicotinic acid Pyridine 
Phenylalanine-Tyrosine Isoquinoline 
Histidine                                                      Imidazole 
Lysine                                    Indolizidine, quinolizidine 
Ornithine Pyrrolidine, pyrrolizidine, tropane 
Tryptophan                                                 Indole 
 
The existence of several structural variations is due to allyl oxidations, oxidative 
coupling, oxidation of aromatic nuclei, esterifications and eterifications. Due to their basic 
characteristics they give positive reactions in precipitation assays, such as those with 
Dragendorff’s, Mayer’s or Bertrand’s reagents (8). 
 
2.1.1. Pyrrolizidine alkaloids 
 
Pyrrolizidine alkaloids (PAs) are constitutively expressed secondary plant defence 
compounds (9, 10). They comprise about 400 different structures isolated from more than 
560 plant species (11), which correspond to ca. 3% of the flowering plants. PAs occur in 
two major forms, a tertiary form and the corresponding N-oxide (12). The occurrence of 
PAs is restricted to Angiosperms, being limited to the families Boraginaceae (all genera), 
Asteraceae (Compositae, tribes Senecioneae and Eupatoriae) and Fabaceae 
(Leguminosae) (genus Crotolaria) (12,13). Almost all PAs can be classified into five major 
structural types (Figure 3), all of them being found in Boraginaceae, to which Echium 
genus belongs (10).  
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Figure 3.  Major structural types of naturally occurring plant pyrrolizidine alkaloids (9): 1 – 
Senecionine type; 2 – Triangularine type; 3 – Monocrotaline type; 4 – Lycopsamine type; 
5 – Phalaenopsine type. 
 
All structures containing a 1,2-double bond are protoxins, being metabolically activated 
by hepatic Cyt P450 enzymes to toxic pyrroles (14). 1,2-Dehydropyrrolizidine ester 
alkaloids (dehydroPAs), predominantly found as their N-oxides, pyrrolizidine N-oxides 
(PANOs), have been reported in both honey and in pollen obtained directly from the plant 
and pollen loads collected by bees (11). All of them are considered hazardous if ingested 
(12). 
In PAs the amino alcohols are called necines, the acid moieties being necic acids (15). 
 
 
2.1.1.1. Biosynthetic pathway 
 
2.1.1.1.1. Biosynthesis of necines 
 
Biosynthesis of PAs starts with the decarboxylation of the amino acids L-arginine and 
L-ornithine, by the action of arginine and ornithine decarboxylase, respectively, originating 
putrescine (16). Homospermidine is then formed from two putrescine molecules. This 
step, the most important one in the biosynthesis of alkaloids, is catalyzed by the specific 
enzyme homospermidine synthase (HS) (16). Homospermidine is cyclized to the 
corresponding intermediate iminium ion, which is reduced with further cyclization to the 1-
hydroxymethylpyrrolizidines isoretronecanole and trachelanthamidine. Subsequent 
hydroxylation and dehydration afford retronecine that usually is a basic constituent of toxic 
pyrrolizidine alkaloids. On the other hand, otonecine, basic component of the otonecine 
alkaloids, is produced from retronecine, presumably by further hydroxylation and 
formation of a ketonic group, with simultaneous cleavage of the C-N bond and N-
methylation (16, 17). 
 
1 5 4 3 2 
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2.1.1.1.2. Biosynthesis of necic acids 
 
Necic acids are mainly composed by L-valine, L-leucine, L-isoleucine and the 
secondary product of the latter, L-threonine. In contrast with the necine biosynthesis, the 
synthesis of necic acids follows different routes. Monocarboxylic acids with five carbon 
atoms, such as angelic, tiglic and sarracinic acid, are generated in the threonine 
metabolism. Threonine can interact with pyruvate to yield isoleucine, which may be 
involved in the formation of necic acids. Isoleucine can be degraded to propionyl-Co A 
and acetyl-Co A via tiglyl-CoA (16). 
Valine is converted into senecioic, viridifloric and trachelanthic acid by reaction with 
activated acetaldehyde. The formation of the ten-carbon atoms-containing dicarboxylic 
acids is only effected by subsequent cyclization of the open-chain necine monocarboxylic 
acid diesters. Thus, senecionine is produced from diangeloylretronecine, in a reaction 
similar to the Michael’s addition proceeding via cationic intermediates (16, 17). 
The different metabolic pathways enable a great variability of necic acids. Biosynthesis 
of dicarboxylic acids takes place in the roots where the alkaloids occur as N-oxides. Being 
available in easily water-soluble form, they are transported to the aerial parts of the plant 
and stored in vacuoles (18, 19). 
 
2.1.1.2. Biological activities 
 
Pyrrolizidine alkaloids have various interesting biological actions, like antimicrobial 
activity. Pharmacological and biological effects, e.g., spasmolytic, anti-histaminic, anti-HIV 
and glucosidase inhibition, have been attributed to some saturated PAs (17). Alkaloid 
producing species are highly protected from herbivores. They have been referred to as 
defence agents against both vertebrate and invertebrate predators, as they are reported 
to be distasteful to them (17). 
 
2.1.1.3. Pyrrolizidine alkaloids in E. plantagineum 
 
Several pyrrolizidine alkaloids N-oxides have been described in E. plantagineum: 
lepanthine, echimiplatine, 7-O-acetyllycopsamine, 7-O-acetylintermedine, echimidine, 3’-
O-acetylechimidine, echiumine and 3’-O-acetylechiumine (20). 
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2.2. Phenolic compounds 
 
Phenolics represent the most abundant and widely spread class of plant secondary 
metabolites, comprising a large range of structures (from simple phenolic acids to 
polymeric molecules with high molecular mass, like condensed or hydrolizable tannins) 
and functions. They can be classified into water-soluble compounds (phenolic acids, 
flavonoids and quinones) and water-insoluble compounds (condensed tannins, lignans 
and cell-wall bound hydroxycinnamic acids) (21, 22). These compounds are synthesized 
during normal development of the plant and play important functions, including support of 
the plant body, protection against biotic and abiotic stresses, herbivore deterrence and 
signalling in plant-plant and plant microbe interactions (21, 22).  
 
Phenolic compounds are thought to be the active ingredients in many dietary plants 
and traditional medicines used for the treatment of disorders related to oxidative stress 
and inflammation (22). There is increasing evidence that phenolic compounds present in 
natural foods may reduce the risk of chronic diseases, such as cancer, inflammation, 
cardiovascular and neurodegenerative disorders (22). Therefore, there is a growing 
interest in phenolic compounds of fruits and vegetables, which may promote human 
health or lower the risk of disease (23). 
 
Phenolic compounds can be classified into distinct families according to their basic 
molecular structure. Particular emphasis is given here to flavonoids, as the phenolic 
compounds previously found in E. plantagineum belong to this class (Table 2) (14, 22).
  
 
Table 2. Classification of flavonoids according to their basic chemical structure. [adapted from (8)]. 
 
 
Flavones                                                                         Flavanones                                        Flavonols 
 
  
 
          
 
R=H, apigenin      R=H, naringetin                          R=H, kaempferol      
R=OH, luteolin                                                                                                R=OH, eriodictyol                                             R=OH, quercetin 
 
Flavan-3-ols                                                                     Flavan-3,4-diols                                            Dihydroflavonols 
                        
       
       
 
 
 
R=H, afzelechin          R=H, leucopelargonidin                                            R=H, dihydrokaempferol 
R=OH, catechin                              R=OH, leucocyanidin                                                             R=OH, dihydroquercetin 
 
Chalcones               Aurones      Anthocyanidins 
 
      
  
 
R=H, isoliquiritigenin                   hispidol          R=H, pelargonidin       
R=OH, butein                        R=OH, cyanidin 
1
4
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2.2.1. Flavonoids 
 
Flavonoids are compounds with low molecular weight and their structure is determined 
by a specific C15 system (C6-C3-C6) of three rings, two of them (A, B) aromatic and one 
pyran type (C) (Figure 4) (22). 
 
 
 
 
Figure 4. General structure of flavonoids. 
 
These compounds are the most abundant group of phenolics and are divided into 
distinct subclasses according to the oxidation level of the central heterocyclic ring (Table 
2).  
The different stuctures of flavonoids come from various patterns of substitution through 
hydroxylation, methoxylation, sulfonation, acylation or glycosylation. The structural 
differences significantly affect their absorption, metabolism and bioactivities in vivo (21, 
33). 
There is marked evidence that diets rich in fruits and vegetables provide a reduced risk 
of chronic diseases. Flavonoids and related phenolic compounds that occur in plant-
derived foods have been associated to these protective effects (21).  
Anthocyanins are some of the most abundant flavonoids present in plants. The dark 
blue colour of E. plantagineum is a feature that distinguishes it from other pollen types. 
The anthocyanins profile of bee pollen loads presenting this dark blue/purple colour, like 
those from pollinic type E. plantagineum, has not been well studied (37). 
 
2.2.2. Biosynthetic pathway 
 
These compounds show great structural diversity, yet have some structural similarities 
because their biosynthetic origin derives from the aromatic amino acids phenylalanine and 
tyrosine (8). 
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The synthesis of aromatic compounds starts in plastids with the shikimic acid pathway 
and results in the production of three aromatic amino acids, tyrosine, phenylalanine and 
tryptophan (Figures 5 and 6). L-Phenylalanine occupies a key position as the precursor of 
the phenylpropanoid pathway. The cytoplasmic enzyme phenylalanine ammonia-lyase 
(PAL) removes the amino group from phenylalanine and yields trans-cinnamic acid, which 
is a substrate for a Cyt P450 monoxygenase. The product is p-coumaric acid, which can 
be further modified, usually by esterification with coenzyme A. The resulting pool of 
coumaroyl-CoA in the cytoplasm is the source of the synthesis of primary products, 
monolignols and lignin, and of a large number of natural products, the vital flavonoids and 
their derivatives and defensive compounds, such as coumarins (8). 
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Figure 5. Shikimic acid pathway (simplified overview). 
Shikimic acid 
Tryptophan Phenylalanine Tyrosine 
trans-Cinnamic acid 
p-Coumaric acid 
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Benzoic acid 
Quinones (rings) 
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Volatiles 
Coumarins 
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Polyketides, 
flavonoids, 
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Monolignols Lignin 
Chorismic acid 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Simplified synthesis of flavonoids and tannins. 
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2.2.3. Extraction, separation and identification 
 
The most important steps for the analysis of phenolic compounds are sample preparation 
and extraction, followed by identification and quantification using spectrophotometry, gas 
chromatography (GC), high performance liquid chromatography (HPLC) or capillary 
electrophoresis (CE) methods (25). 
The most common techniques to extract phenolic compounds employ solvents, either 
organic or inorganic. There are several parameters that may influence the yield of phenolics, 
including extraction time, temperature, solvent-to-sample ratio, the number of repeated 
extractions of the sample, as well as the solvent type. Besides, the optimum recovery of 
phenolics is different from one sample to another and relies on the type of plant and its active 
compounds. The choice of the extraction solvent, such as water, acetone, ethyl acetate, 
alcohols (methanol, ethanol and propanol), as well as of its mixtures, will influence the yield 
of phenolics extracted (25). 
 
The association with ultrasounds enhances the process, with consequent reduction of the 
extraction time. Ultrasounds cause disruption of cell walls, reduction of particle size and 
enhancement of the mass transfer of cell contents to the solvent, by the collapse of the 
bubbles produced by cavitation, which leads to membrane’s destruction (26, 27). 
 
One of the disadvantages of solvent extraction is the co-extraction of other compounds, 
such as chlorophylls, peptides, proteins, sugars and organic acids, among others. To bias 
these interferences, different techniques can be performed, the use of C18 Sep-Pak 
cartridges being the most common (28). 
 
Increasing time and temperature promote analyte solubility; however, plant phenolics are 
generally degraded or undergo undesirable reactions, like enzymatic oxidation by extended 
extraction times and high temperatures (25). 
 
The increase of solvent-to-sample ratio enhances phenolic extraction from plant samples, 
but determining the optimum ratio is advisable, so that the solvent input and saturation 
effects of solvent by phenolics are minimized (25). 
 
Sample matrix and particle size also strongly influence phenolics extraction from plant 
materials. Phenolic compounds may bind to other sample elements, such as carbohydrates 
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and proteins. These linkages can be hydrolysed by addition of enzymes, thereby promoting 
the release of bounded phenolics. Acidic and alkaline hydrolysis is also used in the isolation 
of phenolics from plants and plant products and is important for the stability of these 
compounds in the extract (25). 
 
The purification stage includes removing interfering compounds from the crude extract, 
with partionable solvents and using open column chromatography or an adsorption-
desorption process. Sephadex LH-20, polyamide, Amberlite, solid phase extraction (SPE) 
cartridges and styrene-divinylbenzene (XAD 4, XAD16, EXA-90, EXA 118, SP70), acrylic 
resins (XAD-7, EXA-31) are examples of regularly applied materials to purify phenolics from 
crude sample extracts. However, in most studies, SPE is used for purification and partial 
concentration prior to separation using HPLC (25). 
 
Several techniques are used for the analysis of phenolics, namely thin-layer 
chromatography, gas chromatography, capillary electrophoresis, high-speed counter current 
chromatography, supercritical fluid chromatography, among others, reversed-phase HPLC 
being the preferred one for separation and quantification of phenolic compounds from plant-
food material (25). 
 
Various factors affect HPLC analysis of phenolics: sample purification, mobile phase, 
column type and detector (24). As referred below, HPLC equipment, provided with a 
reversed-phase C18 (RP-C18) column and diode array detector (DAD), and polar acidified 
organic solvents are most used to analyse purified phenolics. Usually, HPLC sensitivity and 
detection is based on purification of phenolic compounds and pre-concentration from 
complex matrices of crude plant extracts. The retention time of phenolic compounds is higher 
for substances that are less polar (flavonoids), while polar molecules (phenolic acids) are 
eluted more easily. However, if the compound contains apolar substituents, such as 
methoxyl groups, retention time increases; if it includes sugars or quinic acid residues it 
tends to elute before the corresponding free compound. So, retention time can be used as an 
indicator of polarity, allowing predicting the class of metabolite according to the 
chromatographic behavior (25). 
 
The main eluents used in the HPLC analysis of phenolics are acetonitrile and methanol, or 
their aqueous mixtures. In some cases, ethanol, tetrahydrofuran (THF) and 2-propanol have 
been used. To avoid the ionization of phenolic and carboxylic groups during identification, it 
is necessary to maintain the pH of the mobile phase between 2 and 4, which will improve 
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both retention time and resolution. Therefore, aqueous acidified mobile phases 
predominantly contain acetic acid, but formic and phosphoric acids or phosphate, citrate and 
ammonium acetate buffers at low pH have also been used (25). 
A gradient elution system is more commonly applied than an isocratic one (28), due to the 
chemical complexity and similarity of phenolic compounds. 
 
The selection of the appropriate column is another critical factor in identifying phenolics. 
Based on the polarity, different classes of phenolics can be detected using silica-bonded C18 
or RP-C18 column, 10-30 cm in length, 3.9-4.6 mm internal diameter and 3-10 μm particle 
size. Most HPLC analyses of phenolic compounds are carried out at room temperature. 
HPLC running time is the other factor that influences the detection of phenolics and can 
range from 10 to 150 minutes (25). 
 
Phenolic compounds are frequently detected using UV-Vis and DAD detectors, at 
wavelengths ranging from 190 to 600 nm. DAD has the great advantage of supplying a wide 
range of information from a single run, as each class has a characteristic UV-Vis spectrum 
(27). Moreover, it gives the possibility to determine the correct wavelength to quantify the 
compounds and evaluate peak purity (30). Other methods also used are fluorimetric, 
colorimetric arrays, DAD coupled with fluorescence and chemical reaction-detection 
techniques (25).  
HPLC coupled with mass spectrometry (MS) detector is highly sensitive and is able to 
achieve high specificity due to the mass selectivity of detection. Although UV-Vis information 
is a very important analytical tool, it may not be sufficient for the complete characterization of 
a complex mixture (25). Electrospray ionisation (ESI) is the method better suited to couple 
HPLC with MS (31) when the purpose is to analyse thermally unstable compounds with 
higher molecular weights and polarity. As this technique has a good sensitivity for flavonoids 
glycosides present in plant extracts, it is one of the most widely used (28). 
 
 
2.2.4. Biological activities 
 
The growing interest in phenolic compounds, especially flavonoids, is mainly due to their 
antioxidant potential and the association between their consumption in fruits and vegetables 
and the prevention of some diseases, mainly those associated to oxidative stress, like 
degenerative ones (cancer, multiple sclerosis, autoimmune, Alzheimer’s and Parkinson’s 
diseases) (30, 36). Active oxygen free radicals are involved in oxidative stress, being 
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implicated as causative agents in the conditions metioned above (36). These species can be 
produced both by normal metabolism and by external influences, like UV light and 
carcinogens. When produced in quantities that overload the body’s natural antioxidant and 
repair defence system, they can bring about breakdown of vital components, such as 
coenzymes, neurotransmitters and macromolecules (e.g., nucleic acids, proteins, lipids and 
carbohydrates) (36). Living cells have a limited capacity to nullify the activity of these 
oxidative free radicals. The regular intake of phenolic compounds can improve the protection 
of vital cellular components and, thus, their physiological function, bringing health benefits to 
the individual (36). 
 
The antioxidant properties of phenolic compounds depend on the chemical structure, 
nucleus rearrangement and the presence of functional groups (32, 33). Phenolic compounds 
have an aromatic ring bearing one or more hydroxyl groups and their structure may vary from 
that of a simple phenoIic molecule to that of a complex high molecular mass polymer. In the 
presence of free radicals phenolics have the capacity to stabilize the unpaired electron, by 
donating a hydrogen atom of their hydroxyl groups, and stabilize the phenoxyl radical so 
formed, converting it into an innocuous molecule (30, 32). 
 
Quercetin (3,3’,4’,5,7-pentahydroxylflavone) is a flavonol-type flavonoid ubiquitously 
present in vegetables (Figure 7). This compound has high antioxidant capacity, directly 
scavenging reactive oxygen species (ROS) or effectively inhibiting ROS-generating enzymes 
(e.g. xanthine oxidase, lipoxygenase) (34). This is mainly due to the presence of the two 
hydroxyl groups in ring B. In addition, the presence of a 3-OH group increases the 
antioxidant activity, since it turns planar the conformation of ring B, allowing conjugation to 
occur and an electronic stability displacement reaction (32). Also, the double bond between 
C2 and C3 influences electronic displacements and maintains the planar conformation. This 
explains why flavonols and flavan-3-ols are generally the classes of flavonoids with stronger 
antioxidant activity (32). 
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Figure 7. Quercetin (3,3’,4’,5,7-pentahydroxylflavone). 
 
Hydroxycinnamic acids have some structural features similar to those of flavonoids 
(aromatic ring bearing one or more hydroxyl groups, double bond, carbonyl group) that may 
be important for their antioxidant capacity. Furthermore, phenolic compounds are also known 
to increase cell levels of antioxidant enzymes, like superoxide dismutase, glutathione 
peroxidase and catalase, and to inhibit the pro-oxidant ones, such as xanthine oxidase and 
lipoxygenases (35). 
 
2.2.5. Phenolic compounds in E. plantagineum 
 
Several coloured and non-coloured flavonoids were described in E. plantagineum pollen: 
 
- Coloured flavonoids (anthocyanins) - delphinidin-3-O-glucoside, delphinidin-3-O-
rutinoside, cyanidin-3-O-glucoside, cyanidin-3-O-rutinoside, petunidin-3-O-glucoside, 
petunidin-3-O-rutinoside, peonidin-3-O-rutinoside, malvidin-3-O-rutinoside, cyanidin-3-(6”-
malonylglucoside) (37). The anthocyanin present in highest amount is petunidin-3-O-
rutinoside, accounting for 80 to 90% (37) (Figure 8A). 
 
-  Non-coloured flavonoids - quercetin-3-O-sophoroside, isorhamnetin-3-O-rutinoside, 
quercetin-3-O-neohesperoside, kaempferol-3-O-sophoroside, kaempferol-3-O-(4”-
rhamnosyl)-neohesperidoside, kaempferol-3-O-neohesperidoside derivative, kaempferol-3-
O-(3”/4”-acetyl)-neohesperidoside, kaempferol-3-O-neohesperidoside-7-O-rhamnoside, 
kaempferol-3-O-glucoside, kaempferol-3-O-rutinoside, kaempferol-3-O-(4”/3”-acetyl)-
neohesperidoside isomer (14). Of these, the most abundant determined flavonoid is 
kaempferol-3-O-neohesperidoside (14) (Figure 8B). 
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Figure 8. Chemical structures of petunidin-3-O-rutinoside (A) and kaempferol-3-O- 
neohesperidoside (B). 
 
 
3. Primary metabolism 
 
3.1. Organic acids  
 
Organic acids are naturally occurring compounds present in foods of plant origin, as well 
as produced during fermentation of foods. Organic acids metabolism is involved in several 
cellular biochemical pathways, including energy production, formation of precursors for 
aminoacids biosynthesis and, at the whole plant level, in modulating adaptation to the 
environment (40). 
 
The high accumulation of organic acids in plant tissues is most probably due to their 
important role as photosynthetic intermediates. However, organic acids have a potential role 
as metabolically active solutes for the osmotic adjustment and the balance of cation excess. 
Organic acids also participate as key components in the mechanisms that some plants use 
to cope with nutrient deficiencies, metal tolerance and plant–microbe interactions, operating 
at the root–soil interface (38). 
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3.1.1. Biosynthetic pathway 
 
Organic acids are mainly produced in mitochondria through the tricarboxylic acids or 
Krebs cycle and, to a lesser extent, in the glyoxysome as part of the glyoxylate cycle (Figure 
9). Because of the catalytic nature of the Krebs cycle, organic acids are present only in very 
small pools in the mitochondria and are preferentially stored in the vacuole (40). The most 
common organic acids are the carboxylic acids, whose acidity is related with their carboxyl 
group. Malonic and acetic acids are precursors of fatty acids and also of flavonoids (together 
with shikimic acid) (40). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Krebs cycle. 
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3.1.2. Extraction, separation and identification 
 
Organic acids are soluble in water and hydroalcoholic solvent mixtures. The extraction of 
organic acids is increased when the solvent is acidified and further purification of the extracts 
is achieved using SPE (41, 42). 
 
HPLC is a particularly useful method to separate polar or moderately polar compounds, 
such as organic acids (43). An ion exclusion column, consisting on an ion-exchange resin, 
splits ionised and neutral species. While ionised compounds are rejected by the resin and 
eluted through the column, the neutral and slightly ionised ones are retained. This allows 
proper separation of acid molecules from highly ionised compounds (44). Elution can be 
isocratic or in gradient mode, the first being more used for the determination of organic 
compounds (45, 46). 
 
The detection of organic acids can be achieved by several techniques, such as UV, MS 
and fluorescence (43). The most commonly used is UV, in which case external standards for 
compounds’ identification and quantification are necessary (41). 
 
3.1.3. Biological activities 
 
Organic acids have long been utilized as food additives and preservatives for preventing 
food deterioration and extending the shelf-life of perishable food ingredients (38). Although 
the mechanisms of organic acids antibacterial effect are not fully understood, they are 
capable of exhibiting bacteriostatic and bactericidal properties, depending on the 
physiological status of the organism and the physiochemical characteristics of the external 
environment. Given the weak acid nature of most of these compounds, pH is considered a 
primary determinant of effectiveness, because it affects the concentration of undissociated 
acid form. It has been traditionally assumed that undissociated forms of organic acids can 
easily penetrate the lipid membrane of the bacterial cell and once internalized into the neutral 
pH of the cell cytoplasm dissociate into anions and protons (38, 39). The generation of these 
species potentially presents problems for bacteria that must maintain a neutral cytoplasm to 
sustain macromolecules. The exportation of excess of protons requires consumption of 
cellular adenosine triphosphate (ATP) and may result in depletion of cellular energy (38, 39). 
Other toxicity mechanisms have been proposed for organic acids, like membrane disruption, 
inhibition of essential metabolic reactions, stress on intracellular pH homeostasis and the 
accumulation of toxic anions (39, 47, 48). 
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They can be interesting to prevent several diseases like cancer and atherosclerosis (47). 
At industrial level they can be used as flavourings, preservatives and antioxidants. The 
utilization of organic acids is expected to increase because of the increasing demand for 
organic foods (48). 
 
3.2. Fatty acids 
 
  Fatty acids can be represented by the general formula RCOOH, in which R corresponds 
to an alkyl chain. Long-chain fatty acids with an even number of carbon atoms are important 
for human nutrition and metabolism (12 to 26). These metabolites can be classified 
according to the degree of saturation. Saturated fatty acids contain a flexible alkyl chain, 
without any double bond between carbon atoms; the monounsaturated have a double bond 
and the polyunsaturated have at least two of those bindings. There are cis or trans isomers 
(48). 
 As the fatty acid carboxylic group has a pKa near 4.8, these molecules are found in body 
fluids in the ionized form. Humans are able to synthesize the majority of the fatty acids, 
including saturated, monounsaturated and some polyunsaturated ones. However, linoleic 
and α-linolenic acids (Figure 10) are exceptions, being considered essential fatty acids (49). 
 
 
 
 
 
 
Figure 10. Chemical structure of (A) linoleic acid (B) α-linolenic acid. 
 
 
3.2.1. Biosynthetic pathway 
 
Echium oil is a vegetable oil extracted from the seeds of E. plantagineum containing 
notable amounts of both ω-6 and ω-3 PUFA, y-linolenic acid (GLA) and stearidonic acid 
(SDA), respectively. Both SDA and GLA are the immediate products of the rate-limiting ∆6-
desaturase step and, due to the efficiency of the elongase and ∆5-desaturase-mediated 
steps, are readily converted to long chain PUFAs (Figure 11) (50, 51). 
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  α-Linolenic acid          α-Linoleic acid 
           Δ6-desaturase 
 
  Stearidonic acid        y-Linolenic acid 
           elongase           
          1–series PG  
           
         Eicosatetraenoic acid          Dihomo y-linolenic acid 
          Δ5-desaturase    
3-series PG        3-series LT 
         Eicosapentaenoic acid 
5-series LTV        elongase    2-series PG 
           
  Docosapentaenoic acid   Arachidonic acid  
          elongase     
         Δ-6-desaturase   4-series LT 
          β-oxidation 
  Docosahexaenoic acid       
 
Figure 11. Metabolic pathway of ω-3 and ω-6 polyunsaturated fatty acids and derived 
eicosanoids [adapted from (51)]. LT: leukotriens; LTV: leukotriens series 5; PG: 
prostaglandins. 
 
 
3.2.2. Extraction, separation and identification 
 
The solvents used for fatty acids extraction should offer a good polarity range to extract 
both the polar lipids from cellular membranes and the non-polar lipids, a mixture of 
chloroform and methanol (2:1) being the most used (52). 
 
The separation of fatty acids is mainly performed by GC-MS. In this context, the samples 
must be derivatized to give rise to less polar and sufficiently volatile compounds, which could 
be eluted at reasonable temperatures without undergoing thermal decomposition or 
molecular rearrangements (53). 
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Different methods, like esterification, silylation and acetylation, can be used for 
derivatization. Esterification is the most commonly used and can be done with an appropriate 
alcohol, such as methanol, and an inorganic acid to catalyse the reaction. Boron trifluoride or 
boron trichloride are very useful for forming ester derivatives, the reactions catalysed by the 
first being faster (53). 
 
3.2.3. Biological activities 
 
Lipids are an important component of the diet. There is a growing awareness that diet in 
general, and lipids in particular, are important in the maintenance of good health and in the 
development and treatment of some diseases. Fatty acids and their triacylglycerols represent 
a wide range of structures, and it is the total amount of these and the balance between the 
various types that it is significant (54). 
The effects of fatty acids are complex and greatly vary according to the dose and the 
nature of the molecule. The knowledge on the beneficial effect of ω-3 long-chain PUFAs on 
inflammatory and autoimmune diseases, like atherosclerosis, cancer, rheumatoid arthritis, 
asthma, Alzheimer’s disease and others, has dramatically increased during recent years 
(55). The literature also refers the fatty acids importance in the bone matrix, since they 
interfere with signalling pathways of osteoclasts and osteoblasts, favouring bone growth (56).  
 
Among PUFAs, the ones belonging to ω-3 and ω-6 families are highlighted. The human 
organism is not able to synthesize them due to the absence of specific enzymes. So, it is 
necessary to obtain them from the diet (57, 58). These fatty acids are recognized by their 
ability to lower serum cholesterol levels, leading to the reduction of blood pressure, thus 
decreasing the risk of cardiovascular disease (59).  
 
3.2.4. Fatty acids in E. plantagineum 
 
It is known that pollen contains all nutrients, including lipids, which are necessary for plant 
growth and development. As far as we know, fatty acid content of E. plantagineum bee 
pollen has not determined. Nevertheless, the fatty acid composition of other tissues is well 
studied. 
  Echium plantagineum seed contains a highly polyunsaturated oil: 16% oleic acid (OA, 
18:1 n-9), 19% linoleic acid (LA, 18:2 n-6), 10% γ-linolenic acid (GLA, 18:3 n-6), 30% α-
linolenic acid (ALA, 18:3 n-3) and 13% stearidonic acid (SDA, 18:4 n-3). By their metabolism, 
this natural ratio of fatty acids delivers enhanced plasma concentrations of eicosapentaenoic 
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(EPA, 20:5 n-3), docosapentaenoic (DPA, 22:5 n-3) and dihomo-γ-linolenic (DGLA, 20:3 n-6) 
acids, without increasing the concentrations of arachidonic acid (AA, 20:4 n-6) (51). Almost 
all of the fatty acids belong to ω-3 family (60). 
 
  The main fatty acid in E. plantagineum leaf is ALA (61). Macaronesian E. plantagineum 
leaves have a high content of the following saponifiable lipids: 16:0 (20.26%) and 18:3 n-3 
(29.43%) (61).  
 
4. Inflammation 
 
  Inflammation is a physiological response induced by microbial infection or damage to 
living tissues. A major trigger of inflammation is the recognition of microbes by specific 
receptors of the innate immune system, which play a crucial role in the induction of early 
signals initiating and establishing the inflammatory setting (62). It is a defence mechanism 
that evolved in higher organisms to protect them from infection and injury. A main function of 
inflammation is to resolve infection and to repair damage in order to achieve homeostasis 
equilibrium (62). Thus, the ideal inflammatory response is rapid and destructive, yet specific 
and self-limiting. This is a process involved in the so-called acute inflammation because it 
lasts only a few days, allowing the aggressive agent to be localized and eliminated and the 
organism to heal. A response of longer duration is referred to as chronic inflammation, when 
chronic infectious or inflammatory disorders cause more damage to the host than the 
microbe (62). 
 
  Inflammation and the immune system are intimately related. So, an over activation of 
innate immune response can cause chronic infection or chronic inflammation, and hence 
disease, due to an inefficient regulation or resolution of the inflammatory response 62
Oxidative stress is implicated in the inflammatory processes at the molecular level. 
Oxidative stress is a status characterized by the production of high amount of oxidants or low 
level of antioxidants, which results in an imbalance between oxidant and antioxidant systems 
causing damage. Oxidative stress can be extrinsically induced by environmental factors and 
intrinsically by endogenous factors, such as the electron transport chain in mitochondria, 
some enzyme activities (NADH oxidase and nitric oxide synthase) and respiratory burst from 
inflammatory cells (63). 
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Inflammation induces reactive oxygen species and reactive nitrogen species production 
via respiratory bursts and inflammatory cytokines, which can activate many oxidant 
generating enzymes, such as inducible nitric oxide synthase (iNOS), cyclooxygenase 2 
(COX2), myeloperoxidase (MPO) and eosinophil peroxidase (EPO) (63). 
  Eicosanoids, including prostaglandins (PGs), leukotrienes (LTs) and lipoxins (LXs), are 
signalling molecules that are generated primarily through an oxidative pathway from AA 
(Figure 12). They are also generated from pathways originating from EPA and DGLA (64). 
AA-derived eicosanoids exert complex control over a wide range of physiological processes. 
Eicosanoids production is considerably increased during inflammation and their biosynthetic 
pathways are of particular clinical relevance because their products are involved in the 
pathogenesis of various pathologies related to immune functions (64). 
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Figure 12. Synthesis of eicosanoids through an oxidative pathway from arachidonic acid 
(AA).  Non-specific activating stimuli, including cytokines, hormones and stress, lead to AA 
release from membrane phospholipids by phospholipases, particularly cytosolic 
phospholipase A2 (cPLA2). Free AA can be converted to bioactive eicosanoids through the 
cyclooxygenase (COX), lipoxygenase (LOX) or Cyt P450 epoxygenase pathways. LOXs 
catalyse the formation of LTs, 12(S)hydroperoxyeicosatetraenoic acids and lipoxins (LXs). 
COX isozymes (constitutive COX-1 and inducible COX-2) catalyse the formation of PGH2, 
which is converted by cell-specific PG synthases to biologically active products, including 
PGE2, PGF2α, PGI2 and TXA2, collectively known as prostanoids. The Cyt P450 
epoxygenase pathway catalyses the formation of hydroxyeicosatetraenoic acids (HETEs) 
and epoxides [from (64)]. 
 
The biosynthesis of eicosanoids depends on the availability of free AA. When tissues are 
exposed to diverse physiological and pathological stimuli, such as growth factors, hormones 
or cytokines, AA is produced from membrane phospholipids by the action of phospholipase 
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A2 (PLA2) enzymes and can then be converted into different eicosanoids. AA can be 
enzymatically metabolized by three main pathways: Cyt P450 epoxygenase, 
cyclooxygenases (COXs) and lipoxygenases (LOXs) (Figure 12). The Cyt P450 
epoxygenase pathway produces hydroxyeicosatetraenoic acids (HETEs) and epoxides. The 
COX pathway produces PGG2 and PGH2, which are subsequently converted into PGs and 
thromboxanes (TXs). 
 
There are two COX isoforms, commonly referred to as COX-1 and COX-2 (65). It is the 
enzyme that catalyses the rate-limiting step in prostaglandin synthesis, converting AA into 
prostaglandin H2α, which is then further metabolized to prostaglandin E2 (PGE2), PGF2α, 
PGD2 and other eicosanoids. 
 COX-1 is constitutively expressed in many tissues (encoded by a constitutively expressed 
gene) and plays an important role in tissue homeostasis. COX-2, which can be expressed in 
a variety of cells and tissues, is an inducible isoform (encoded by an immediate early 
response gene) and growth factors, cytokines and tumour promoters stimulate its expression 
(66). Despite the structural similarity between the two isoforms, COX-1 and COX-2 differ 
substantially in the regulation of their expression and their roles in tissue biology and 
disease. 
 
  LOXs are more numerous and convert AA into diverse hydroperoxyeicosatetraenoic 
acids (HPETEs) and HETEs. 5-HETE is converted into the leukotriene LTA4, which is the 
precursor of LTB4, cysteinyl-LTs (CysLTs) (including LTC4, LTD4 and LTE4) and LXs. 
Synthesis of LXs is dependent on the activity of the requisite interacting LOXs and the 
proximity of cells that are necessary for the metabolism of AA to the LX end-products. In 
some instances, the metabolite is transferred to another cell that, in turn, converts it into 
another compound. For example, PGI2 and LXA4 can be produced during cell–cell 
interactions, utilizing enzymes in adjacent cells. PGI2 is produced from PGH2 (of platelet 
origin) by the vascular epithelium or lymphocytes. Similarly, LTA4 produced by neutrophils 
can be converted into LTC4 by vascular epithelium or platelets, or into LTB4 by erythrocytes. 
Thus, biosynthesis of different eicosanoids is dependent on local production and distribution 
of specific precursors and enzymes in specific cells (64). 
 
4.1. In vitro models 
 
Macrophages are a major component of the mononuclear phagocyte system that consists 
Introduction 
34 
 
of closely related cells of bone marrow origin, including blood monocytes, and tissue 
macrophages. They play a critical role in the initiation, maintenance, and resolution of 
inflammation, being activated and deactivated in the inflammatory process. Activation signals 
include cytokines (interferon gamma, granulocyte-monocyte colony stimulating factor, and 
tumor necrosis factor alpha (TNF-α)), bacterial lipopolysaccharide (LPS), extracellular matrix 
proteins, and other chemical mediators. Inhibition of inflammation by removal or deactivation 
of mediators and inflammatory effector cells permits the host to repair damaged tissues. Anti-
inflammatory cytokines (interleukin 10 and transforming growth factor beta) and cytokine 
antagonists that are mainly produced by macrophages deactivate activated macrophages. 
Macrophages participate in the auto-regulatory loop in the inflammatory process. Because 
macrophages produce a wide range of biologically active molecules participating in both 
beneficial and detrimental outcomes in inflammation, therapeutic interventions targeting 
macrophages and their products may open new avenues for controlling inflammatory 
diseases (67). 
 
  The cellular model of LPS-stimulated macrophages is widely used to assess anti-
inflammatory activity (68, 69, 70). It is well known that infection of cells by microorganisms 
activates the inflammatory response due to the recognition by macrophages receptors of 
LPS present in microorganisms’ cell wall: the initial sensing of infection is mediated by innate 
pattern recognition receptors that are expressed by macrophages dendritic cells and various 
nonprofessional immune cells. Although inflammation is a protective response of the body to 
ensure removal of detrimental stimuli, as well as a healing process for repairing damaged 
tissue, the stimulation of macrophages, initiated by microorganisms (or other agent) can 
result in the overproduction of inflammatory mediators like PGE2 and PGI2, which enhance 
edema formation and leukocyte infiltration by promoting blood flow in the inflamed region (71, 
72). 
 
5. Allergy 
 
  Bee pollen has been used as a “perfect health food” for many centuries and its benefits 
have been widely lauded. Modern research has also shown that bee pollen mainly 
possesses the therapeutic effects of improving the cardiovascular system, enhancing body 
immunity, delaying aging, maintaining the digestive system and preventing prostate 
degeneration (73). Nevertheless, in sensitized individuals it can cause allergic reactions.  
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  Allergies are immune-mediated hypersensitivity reactions that can affect various organs, 
most commonly the skin, airways and gastro-intestinal tract (74). The route of exposure, 
dose and function of the allergen are crucial to mount an allergic sensitization (74). There is 
ample evidence that allergic disorders, such as asthma, rhinitis, and atopic dermatitis, are 
mediated by oxidative stress (75). 
 
  Allergy is mainly classified into four types, type I being the most common allergic 
reaction associated with asthma and allergic dermatitis. The type I allergic reaction is 
provoked by cross-linkage of an antigen, referred to as allergen to immunoglobulin E (IgE) 
bound on the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils. 
The cross-linked FcεRI activates the Src family non-receptor tyrosine kinases Lyn and Fyn. 
Activation of Lyn induces phosphorylation of the Syk kinase that leads to Ca2+ mobilisation. 
As a result, chemical mediators like histamine, eicosanoids and inflammatory cytokines are 
released from intracellular granules (76). Released histamine induces an acute allergic 
response, such as contraction of smooth muscle, vasodilation and increased vascular 
permeability (Figure 13) (76). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Type I allergic disease mechanism. 
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The most important sources of allergens are wind-dispersed pollen grains from trees, 
grasses and weeds, followed by excretions of house dust mites and cockroaches, fungal 
spores, animal dander and insect venoms (74). 
  Notwithstanding the genetic predisposition, there are several factors that contribute to 
the appearance of allergic disease, which can be classified as adjuvant and causal factors. 
As adjuvant factors that cause allergic sensitisation, we can mention biogenic and 
antropogenic factors; irritants, environmental tobacco smoke, infections and exercise cause 
skin and/or airway hyper-reactivity (74). As causal factors, allergens are the main ones 
promoting allergic sensitisation; oligomerisation and surface motifs are responsible for skin 
and/or airway hyperreactivity (74). 
 
 Atopic diseases are characterized by predominance of T helper cell type 2 (Th2)-biased 
immune responses to environmental allergens (77, 78). It is well established that allergen 
specific Th2 cells are the key orchestrators of allergic reactions, initiating and propagating 
inflammation through the release of a number of Th2 cytokines (78). Th2 responses 
constitute a prerequisite for the development of type I hypersensitivity reactions, which lead 
to IgE production and arming of mast cells and basophils with specific IgE. Subsequent 
allergen encounter leads to IgE-mediated mast cell/basophil degranulation and release of 
pro-inflammatory mediators, cytokines, and chemokines that ultimately are responsible for 
the inflammatory response seen in type I hypersensitivity (75) (Figure 14). 
 
In the context of type I allergy, airborne pollen grains have generally been regarded as 
allergen carriers. Aside from allergens, pollens release many other substances with pro-
inflammatory and immune-modulatory effects on cells of the allergic immune response. In 
addition, pollens can carry biogenic and anthropogenic factors that influence allergen 
release, generate novel allergenic epitopes, and modulate the epithelial microenvironment of 
an allergen encounter (74). 
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Figure 14. Interplay between the allergen source, environmental cofactors and cells of the 
allergic immune response during exposure to pollen grains. NADPH, Reduced nicotinamide 
adenine dinucleotide phosphate; ROS, reactive oxygen species; ECP, eosinophil cationic 
protein; MPO, myeloperoxidase; PALMs, pollen-associated lipid mediators [adapted from 
(74)]. 
 
In fact, it has been demonstrated that pollen grains secrete significant amounts of lipids 
that are structurally and functionally homologous to eicosanoids (78): pollen grains not only 
release allergens, but also non-allergic, bioactive and pollen-associated lipid mediators 
(PALMs), which have pro-inflammatory and immune-modulatory effects on the cells of the 
allergic immune response. Pro-inflammatory PALMs (eg. oxylipins) attract and activate 
eosinophils and neutrophils independently of the sensitization status of the donor (i.e., from 
allergic and non-allergic donors), suggesting that they act primarily as an adjuvant that can 
enhance inflammatory processes, such as during the elicitation of the allergic response (74). 
Immuno-modulatory PALMs like E1 phytoprostanes inhibit dendritic cells (DC) production of 
IL-12 and Th1-type chemokines and increase the capacity of DCs to induce Th2 cell 
differentiation and recruitment, which indicates that they support the generation of a Th2 cell-
dominated allergic immune response (74). Finally, pollen releases non-allergic nicotinamide 
adenine dinucleotide phosphate oxidases, which have detrimental effects on airway epithelial 
cells through the generation of reactive oxygen species (74). 
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5.1. In vitro models 
 
 During immediate-type allergy (type I hypersensitivity), histamine is released from 
activated mast cells via a degranulation process by IgE-allergenic stimulation. Along with 
histamine release β-hexosaminidase is simultaneously degranulated from the same activated 
cells (79). Thus, β-hexosaminidase activity can be used as a biomarker of allergic response 
of the mast cells. As indicated above, 5-lipoxygenase (5-LOX) is an enzyme that produces 
LTs from AA. Because LTs are mediators of some allergic reactions, such as bronchial 
asthma (80), 5-LOX is regarded as an enzyme that induces allergic response. Accordingly, 
inhibition of the release of β-hexosaminidase and 5-LOX is well correlated with anti-allergic 
action. On the other hand, the recruited monocytes and lymphocytes and their secreted 
cytokines like IL-1β play an important role in delayed-type allergic response (type IV 
hypersensitivity) (81). 
 
The rat basophilic leukemic (RBL-2H3) cell line has been widely used for allergy and 
immunological research (82, 83, 84). The release of β-hexosaminidase enzyme, a marker of 
degranulation in mast cells and basophils, allows estimating the anti-allergic potential of new 
drugs in vitro (85). 
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6. Objectives 
 
 
The main objectives of this dissertation were: 
 
1. To improve the knowledge on the chemical composition of E. plantagineum bee 
pollen; 
 
2. To evaluate the potential of E. plantagineum bee pollen on inflammation and to 
elucidate the mechanisms underlying the anti-inflammatory effect; 
 
3. To evaluate the activity of E. plantagineum bee pollen on allergy and to assess the 
mechanisms behind its effect; 
 
4. To evaluate the protective effect of E. plantagineum bee pollen against oxidative 
stress; 
 
5. To establish possible relationships between the chemical composition and the 
biological activity of E. plantagineum bee pollen. 
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1. Standards and reagents 
 
LPS from Salmonella enterica, quercetin-3-O-rutinoside, lipoxygenase from Glycine max 
(L.) Merr. (type V-S; EC 1.13.11.12), methyl linolelaidate, N-methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA), capric, lauric, palmitic, linolenic, stearic, oxalic, 
aconitic, citric, pyruvic, malonic, shikimic and fumaric acids, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), methanol, Triton X-100, Tris-HCl, dimethyl sulfoxide 
(DMSO), DL-dithiothreitol (DTT), phenylmethanesulfonyl fluoride (PMSF), calcium ionophore 
A23187, mouse anti-2,4-dinitrophenylated IgE (anti-DNP IgE), albumin from bovine serum 
(BSA), 2,4-dinitrophenylated BSA (DNP-BSA), 4-nitrophenyl N-acetyl-β-D-glucosaminide, 
sodium pyruvate, β-nicotinamide adenine dinucleotide reduced form (NADH),  2’,7’-
dichlorofluorescein diacetate (DCFA-DA), 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB), tert-
butyl hydroperoxide (t-BHP), antipyrene E, phenazine methosulfate (PMS), nitroblue 
tetrazolium chloride (NBT), perchloric acid, glutathione reduced form (GSH), oxidized 
glutathione (GSSG), reduced nicotinamide adenine dinucleotide phosphate (β-NADPH), 2-
vinylpyridine, glutathione reductase (GR, EC 1.6.4.2), 2,4-dinitrophenylhydrazine, 1-chloro-
2,4-dinitrobenzene (CDNB), brilliant blue G, diacetylmonoxime (79 mM in 83 mM acetic 
acid), β-glucuronidase, type H2 from Helix pomatia, sodium linoleate (2 mM in ethanol), 
potassium hydrogen carbonate, hydrogen peroxide, superoxide dismutase (SOD) bovine (EC 
1.15.1.1) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Kaempferol-3-O-rutinoside, kaempferol-3-O-glucoside, delphinidin-3-O-glucoside and 
malvidin-3-O-glucoside were obtained from Extrasynthese (Genay, France). 
ortho-Phosphoric acid 85% was obtained from Panreac (Barcelona, Spain). 
The n-alkane series (C8–C40) was from Supelco (Bellefonte, PA, USA). N-(1-Naphthyl)-
ethylene-diamine dihydrochloride, sodium nitroprusside (SNP) dehydrate, sodium chloride, 
methanol, trichloroacetic acid and acetonitrile were obtained from Merck (Darmstadt, 
Germany) and acetic and sulfuric acids were from Fisher Scientific (Loughborough, UK). 
Ethyl acetate, hydrochloric and formic acids were from BDH Prolabo (Dublin, Ireland).  
Dulbecco’s Phosphate Buffered Saline (DPBS), Dulbecco’s Modified Eagle Medium 
(DMEM), DMEM+GlutaMAX™1, Earle’s Balanced Salt Solution (EBSS), heat inactivated 
foetal bovine serum (FBS), heat inactivated foetal calf serum (FCS) and Pen Strep solution 
(Penicillin 5000 units mL-1 and Streptomycin 5000 mg mL-1) were obtained from Gibco, 
InvitrogenTM (Grand Island, NY, USA). 
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Non-essential aminoacids (NEAA), fungizone (250 μg mL-1 amphotericin B), human 
transferrin (4 mg mL-1) and trypsin-EDTA were purchased from Gibco, InvitrogenTM (Paisley, 
UK). 
Mueller Hinton Broth (MHB) and Mueller Hinton Agar (MHA) media were purchased from 
Liofilchem (Teramo, Italy). 
PGE1, PGE2, tetranor-PGEM, tetranor-PGAM, 20-hydroxy-PGE2, 6-keto-PGF1α, 2,3- 
dinor-6-keto-PGF1α, 11b-PGF2α, 2,3-dinor-6-keto-PGF1α, 11b-PGF2α, 2,3-dinor-11b-
PGF2α, tetranor-PGFM, 9,11-dideoxy-9α,11a-epoxymethano-PGF2α (U-44069), 9,11-
dideoxy-9α, 11a-methanoepoxy-PGF2α (U-46619), 11-dehydrothromboxane B2, 8-iso-
PGF2α, 2,3-dinor-8-iso-PGF2α, 8-iso-15(R)-PGF2α, 8-iso-15-keto-PGF2α, 8-
isoprostaglandin F2α-d4 and 11-dehydro-thromboxane B2-d4 were from Cayman Chemicals 
(Ann Arbor, Michigan, USA).  
 
      Water was treated in a Milli-Q (Miilipore, Bedford, MA, USA) water purification system. 
 
 
2. Plant material 
 
E. plantagineum bee pollen sample was provided by bee-keepers in the Spanish 
Extremadura region. The botanical origin was ascertained by Professor Paula B. Andrade 
(Laboratório de Farmacognosia, Faculdade de Farmácia, Universidade do Porto). Pollen was 
stored protected from light, under desiccating conditions to prevent alteration. When needed, 
samples were ground into a fine powder and kept in a desiccator in the dark until analysis. 
 
 
3. Hydromethanol extract 
 
3.1. Preparation  
 
Bee pollen (0.2 g) was thoroughly mixed with 1 mL methanol-water (7:3), ultrasonicated 
for 1 h and centrifuged at 2,900 × g during 10 min. The supernatant was evaporated under 
reduced pressure at 40 ºC and the dry residue was stored at −20 ºC, protected from light, 
until use. 
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3.2. Alkaloid precipitation tests for alkaloid detection 
 
The presence of alkaloids was discarded by the general alkaloids precipitation tests, 
adding Dragendorff’s (solution of potassium bismuth iodide), Mayer’s (potassium mercuric 
iodide solution) and Bertrand’s (silicotungstic acid solution) reagents to the extract. 
 
3.3. HPLC-DAD analysis of phenolic compounds 
  
The extract was analysed in an analytical HPLC unit (Gilson, Villiers-le-bel, France) as 
before (14), using a LiChroCART column (250  4mm, RP-18, 5 m particle size, 
LiChrospher100 stationary phase; Merck, Darmstadt, Germany). The mobile phase 
consisted of two solvents: water-formic acid (1%) (A) and methanol (B). Elution started with 
30% B and a gradient was used to obtain 40% at 20 min, 50% at 25 min, 60% at 30 min and 
80% at 32 min. The flow rate was 1 mL min-1 and the injection volume 20 μL. Spectral data 
from all peaks were accumulated in the range 240-600 nm and chromatograms were 
recorded at 350 nm. The data were processed on a Unipoint Software system (Gilson 
Medical Electronics, Villiers-le-Bel, France). Peak purity was checked by the software 
contrast facilities. 
 
Phenolic compounds quantification was achieved by the absorbance recorded at 350 nm 
relative to external standards. Because standards of all identified flavonoid derivatives were 
not commercially available, quercetin-3-O-neohesperidoside was quantified as quercetin-3-
O-rutinoside and kaempferol derivatives as kaempferol-3-O-rutinoside, except kaempferol-3-
O-glucoside, which was quantified as itself. Analyses were performed in triplicate. 
 
3.4. HPLC-UV analysis of organic acids 
 
The dry residue of the hydromethanolic extract was dissolved in sulphuric acid 0.01 N. 
The HPLC-UV analysis was carried out as previously reported (85), in a system consisting of 
an analytical HPLC unit (Gilson, Villiers-le-bel, France), with an ion exclusion column 
(Nucleogel Ion 300 OA) in conjunction with a column heating device set at 30 ºC. Elution was 
carried out isocratically at a solvent flow rate of 0.2 mL min-1, with sulphuric acid 0.01 N. The 
injection volume was 20 μL. Detection was performed with an UV-Vis detector set at 214 nm. 
Organic acids quantification was achieved by the absorbance recorded in the 
chromatograms relative to external standards. The data were processed on a Clarity 
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Software system (Data Apex, Prague, Czech Republic). Analyses were performed in 
triplicate. 
  
3.5. GC-IT/MS analysis of fatty acids 
 
3.5.1. Extract purification and derivatization 
 
The extract was purified before fatty acids derivatization. The dry residue of the 
hydromethanolic extract was thoroughly mixed with acidic water (pH 2 with HCl) and applied 
to an Amberlite XAD-2 (Fluka Chemicals, Steinheim, Germany: pore size 9 nm, particle size 
0.3-1.2 mm) column. Sugars and other polar compounds were eluted with the aqueous 
solvent. The retained compounds were eluted with ethanol and the internal standard (IS) 
methyl linolelaidate (100.00 μg mL-1 final concentration) was added. The volume was 
completed to 2.00 mL with ethanol. Fatty acids derivatization was carried out as previously 
described (86). Briefly, an aliquot of 50 μL of purified extract solution was transferred to a 
glass vial, the solvent was evaporated under nitrogen stream and 50 μL of derivatization 
reagent (MSTFA) were added to the dried residue. The vial was capped, vortexed and 
heated for 20 min in a dry block heater maintained at 60 ºC.  
 
3.5.2. GC-IT/MS conditions 
 
Samples were analysed using a Varian CP-3800 gas chromatographer coupled to a 
Varian Saturn 4000 mass selective ion trap detector (Palo Alto, CA, USA) and a Saturn GC-
MS workstation software (version 6.8). A VF-5 ms (30 m x 0.25 mm x 0.25 μm) column 
(Varian) and a CombiPAL automatic auto sampler (Varian) were used. The injector port was 
heated to 250 ºC. Injections were performed in split mode, with a ratio of 1/40. The carrier 
gas was helium C-60 (Gasin, Leça da Palmeira, Portugal), at a constant flow of 1 mL min-1. 
The ion trap detector was set as follows: transfer line, manifold and trap temperatures were 
280, 50 and 180 ºC, respectively. The mass ranged from 50 to 600 m/z, with a scan rate of 6 
scan s-1. The emission current was 50 μA and the electron multiplier was set in relative mode 
to auto tune procedure. The maximum ionization time was 25.000 μs, with an ionization 
storage level of 35 m/z. The injection volume was 2 μL and the analysis was performed in 
Full Scan mode. The oven temperature was set at 100 ºC for 1 min, then increasing 20 ºC 
min-1 to 250 ºC and held for 2 min, 10 ºC min-1 to 300 ºC and held for 10 min. All mass 
spectra were acquired in electron impact (EI) mode. Ionization was maintained off during the 
first 4 min to avoid solvent overloading. Compounds were identified by comparison of 
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retention times and MS fragmentation pattern with those of standards analysed under the 
same conditions and a mass spectra database search was performed using the National 
Institute of Standards and Technology (NIST) MS 05 spectral database. In addition, retention 
index (RI) was experimentally calculated and the values were compared with those reported 
in the literature for GC columns with 5%-phenyl-95%-dimethylpolysiloxane (87, 88). For the 
RI determination, an n-alkanes series (C8-C40) was used. Analyses were performed in 
triplicate. 
 
3.6. Reactive species scavenging assays in cell-free systems 
 
3.6.1. Superoxide anion (O2
-)  
 
The radical was generated by the PMS/NADH system and monitored by the reduction of 
NBT to formazan (89). The reaction mixtures consisted of NADH (166 μM), PMS (2.7 μM), 
NBT (43 μM) and extract (five different concentrations). All components were dissolved in 
phosphate buffer (19 mM, pH 7.4).  
 
The reaction was conducted at room temperature for 2 min and initiated with the addition 
of PMS. The absorbance variation was measured spectrophotometrically at 562 nm, in a 
Multiskan Ascent plate reader (Thermo, Electron Cosporation). Three experiments were 
performed, in which each concentration was tested in triplicate. 
 
3.6.2. Nitric oxide (NO)  
 
Nitric oxide was generated from SNP and measured by the Griess reagent as before (62). 
SNP (6 mg mL-1) in phosphate buffer was mixed with different concentrations of bee pollen 
extract dissolved in the same solvent and incubated at room temperature for 1 h, under light. 
The nitrite accumulated in the reaction medium was then measured. Equal volumes of 
reaction medium and Griess reagent (1:1 mixture (v/v) of 1% sulphanilamide and 0.1% N-(1-
naphthyl) ethylenediamine in 2% H3PO4) were mixed and incubated for 10 min in the dark, at 
room temperature. 
 
The cromophore was determined in a Multiskan Ascent plate reader (Thermo, Electron 
Cosporation) at 562 nm. Five different extract concentrations were tested. Three experiments 
were performed, in which each concentration was tested in triplicate. 
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3.7. Antibacterial capacity 
 
3.7.1. Microorganisms 
 
Nine bacterial species from the American Type Culture Collection (ATCC) were used for 
the experiments: Staphylococcus aureus (ATCC 20231), Staphylococcus epidermidis (ATCC 
20044), Salmonella typhimurium (ATCC 43971), Proteus mirabilis (ATCC 4479), Escherichia 
coli (ATCC 30083), Pseudomonas aeruginosa (ATCC 50071), Bacillus cereus (ATCC 
31000), Enterococcus faecalis (ATCC 20477) and Micrococcus luteus (ATCC 20030). 
Cultures were obtained from the Laboratory of Microbiology, Faculty of Pharmacy, Porto 
University. Stock cultures were maintained on MHA at 4 ºC. 
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3.7.2. Assay 
 
Bacterial inocula were prepared by growing cells in MHB for 24 h, at 37 ºC. Cell 
suspensions were diluted in sterile MHB to provide final cell counts of 1.56  106 colony-
forming units per mL (CFU mL-1). 
Minimum inhibitory concentration (MIC) was determined by employing broth microdilution 
methods based on the Clinical and Laboratory Standards Institute (CLSI) guidelines, 
reference documents M07-A8 and M100-S19, with minor modifications (24). Briefly, the 
suspensions of bacteria cultures were prepared in ampoules containing 2 mL of NaCl 0.85% 
suspension medium (api®, Biomérieux, Marcy l’Étoile, France). After adjusting the turbidity to 
0.5 McFarland, suspensions were diluted in MHB till the final bacterial density of 1.56  106 
CFU mL-1. The MIC of the extract was determined by two-fold serial dilution method, in 96-
well plates: 50 μL of the bacterial suspension was added in each well, which contained 50 μL 
of the extract dilutions in MHB medium. 
The maximum DMSO concentration did not exceed 2.5% (v/v). The plates were incubated 
at 37 ºC in a humidified atmosphere containing 5% CO2, without agitation for 18-24 h for both 
Gram positive and Gram negative bacteria. The MIC was determind as the lowest 
concentration of the extract inhibiting visual growth of the tested culture on the microplate. 
Gentamicin MIC for S. aureus (ATCC 25923) was determined as quality control. Sterility and 
positive controls in MHB medium alone and with 2.5% of DMSO (v/v) were included. Positive 
control wells contained microorganisms without antibiotics. The experiments were performed 
in duplicate and repeated independently three times, yielding essentially the same results. 
 
3.8. Effect on inflammation 
 
3.8.1. Cell culture conditions and treatments 
 
Macrophage RAW 264.7 cells were from ATCC and were kindly provided by Prof. Maria 
S. J. Nascimento (Laboratory of Microbiology, Faculty of Pharmacy, Porto University). They 
were cultured at 37 ºC in DMEM supplemented with 10% FBS and 2% Pen Strep solution in 
a humidified atmosphere of 5% CO2, as previously reported (49). Cells were seeded in 48-
well plates (150 000 cells/ well) and cultured until 80-90% confluence. 
 
  Two groups of RAW 264.7 cells were considered: control group (C group) and LPS-
treated group (T group). Both C and T groups were cultured in cell media containing growing 
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doses of bee pollen extract (C0 and T0: 0; C1 and T1: 0.5; C2 and T2: 1.0; C3 and T3: 2.1; 
C4 and T4: 4.2; C5 and T5: 8.3 mg mL-1; for viability assays concentrations of 16.7 and 33.3 
mg mL-1 were also tested) dissolved in medium containing 0.5% DMSO. Exposure periods 
were 19 h for viability (MTT and LDH assays), NO and L-citrulline assays and 9 h for 
eicosanoids determination. One mg mL-1 of LPS was added to the culture media of T group 
cells after the first hour of extract exposure and this inflammatory stimulus was maintained 
during the following 8 or 18 h. 
 
3.8.2. MTT reduction assay 
 
This assay evaluates cells’ mitochondrial activity, thus allowing determining the number of 
viable cells. The reaction consists on the reduction of MTT to formazan by mitochondrial 
dehydrogenase succinate, this enzyme being active only in cells with intact metabolism and 
respiratory chain (90). 
 
  After the incubation period, RAW 264.7 cells were washed with DPBS and then 
incubated for 30 min with MTT (0.5 mg mL-1 in DMEM). The extent of the reduction to 
formazan within the cells was quantified at 510 nm (69). Results were expressed as 
percentage of the respective control (with or without LPS). Five independent assays were 
performed in triplicate. 
 
3.8.3. Lactate dehydrogenase (LDH) leakage 
 
LDH is rapidly released from damaged cells. The consumption of NADH is kinetically 
measured in the supernatant and is correlated with the amount of extracellular LDH. Thus, 
cell viability is inversely proportional to the amount of released LDH (91). 
Under the assay conditions LDH catalyses the conversion of pyruvate to lactate as NADH 
is oxidized to NAD+. The catalytic activity is determined from the rate of disappearance of 
NADH at 340 nm during 4 min (background correction at 620 nm). Thus, the decrease in 
absorbance is proportional to LDH activity in the sample (92). 
 
  After the treatment period (18 h after LPS addition), an aliquot of the culture medium was 
taken to determine the activity of LDH leaked through cell membranes, according to a 
described procedure (69). The cell monolayer was lysed in the remaining medium with lysis 
buffer (1% triton-X 100 in PBS) to determine total LDH activity. Results are expressed as 
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LDH activity in media relative to total activity (medium plus cell lysate). Five independent 
assays were performed in duplicate. 
 
3.8.4. NO in RAW 264.7 cells culture medium 
 
Nitrite accumulated in the culture medium of C and T-group LPS-stimulated cells was 
measured after 18 h incubation with LPS. This determination was based on the Griess 
reaction (69, 93). Equal volumes of culture supernatant and Griess reagent were mixed and 
incubated for 10 min in the dark, at room temperature. The absorbance was read at 562 nm.  
Five independent assays were performed in duplicate. 
 
3.8.5. Determination of L-citrulline 
 
L-citrulline was quantified using the method of Senshu and collaborators (94), with the 
modifications of Marzinzig and colleagues (95). Briefly, after 18 h incubation with LPS, 100 
μL of culture medium of RAW 264.7 cells of C and T-groups were deproteinized with 200 μL 
of trichloroacetic acid (2.45 M). After centrifugation (10 min; 2,900 x g), 250 μL supernatant 
were mixed with 100 μL of reaction mixture containing 40% (v/v) diacetylmonoxime (79 mM 
in 83 mM acetic acid), 18% (v/v) antipyrine E (47.8 mM in H2O) and 42% (v/v) H2SO4 7.5 M, 
and incubated at 96 ºC for 25 min. The solution was then cooled down to room temperature 
and the absorption was read at 405 nm. Five independent assays were performed in 
duplicate. 
 
3.8.6. Extraction of eicosanoids from macrophages and culture medium 
 
Eicosanoids were determined in the whole cell extracts and in the culture media of RAW 
264.7 cells. The culture medium was collected after 9 h exposure to the extract, 0.005% BHT 
(final concentration) was added and the medium was kept at −80 ºC until eicosanoids 
extraction. To precipitate the serum proteins present in the culture media, 3 mL of 
methanol/HCl 200 mM were added to 2 mL medium and centrifuged at 10,000 x g for 5 min. 
 
After removing the culture medium, cells were lysed by incubation with lysis buffer (50 mM 
Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton X-100, containing 0.005% BHT) for 1 h at 0 ºC. 
Lysates were centrifuged at 8,000 x g for 5 min. The resulting supernatants were kept at −80 
ºC until eicosanoids extraction. 
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Before eicosanoids extraction, one replicate of each culture condition was hydrolysed 
using 5000 UE mL-1 of β-glucuronidase (96). 
After hydrolysis, both hydrolysed and non-hydrolysed supernatants were subjected to 
SPE using Strata X-AW cartridge (100 mg 3mL-1), following the procedure of Medina et al 
(96). Target compounds were eluted with methanol and dried using a SpeedVac 
concentrator. 
 
3.8.7. UPLC-QqQ-MS/MS analysis of eicosanoids 
 
The separation of eicosanoids in the cell lysates and culture medium was performed by 
UPLC coupled to 6460 QqQ-MS/MS (Agilent Technologies, Waldbronn, Germany), using the 
set up of Medina and collaborators (96, 97). 
The quantification of the separate eicosanoids detected was performed using the standard 
compounds PGE1, PGE2, tetranor-PGEM, tetranor-PGAM, 20-hydroxy-PGE2, 6-keto-
PGF1α, 2,3-dinor-6-keto-PGF1α, 11b-PGF2α, 2,3-dinor-11β-PGF2α, tetranor-PGFM, 9,11-
dideoxy-9α,11α-epoxymethano-PGF2α (U-44069), 9,11-dideoxy-9α,11a-methanoepoxy-
PGF2α (U-46619), 11-dehydrothromboxane B2, 8-iso-PGF2α, 2,3-dinor-8-iso-PGF2α, 8-iso-
15(R)-PGF2α, 8-iso-15-keto-PGF2α. The isoprostaglandin F2α-d4 (containing 4 deuterium 
atoms at positions 3, 39,4 and 49) and 11-dehydrothromboxane B2-d4 (containing 4 
deuterium atoms at positions 3, 39, 4 and 49) were used as internal standards (96, 97). 
 
3.9. Effect on degranulation 
 
3.9.1. Cell culture conditions and treatments 
 
The rat basophil cell line RBL-2H3 (from ATCC) was grown in DMEM+GlutaMAX™-I 
supplemented with 10% FBS, 100 U mL-1 penicillin and 100 μg mL-1 streptomycin, under 5% 
CO2 at 37 ºC, in humidified air. For the anti-allergic assays cells were planted at 3 x 10
5 cells 
mL-1 in 24-wells plates (1 mL/well) and treated after reaching confluence. 
 
In the assay using calcium ionophore as stimulus, cells were pre-treated with the extract 
(dissolved in culture medium) 15 min prior to the addition of the ionophore (1 μM in EBSS + 
0.1% BSA) and maintained in culture for another 30 min. Then the supernatant was collected 
and used for the determination of β-hexosaminidase release, whereas the MTT cell viability 
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assay was performed in adherent cells. Three independent assays were performed in 
duplicate. 
In another experiment cells were sensitized with anti-DNP IgE (100 ng mL-1) for 16 h, then 
stimulated for 1 h with DNP-BSA (100 ng mL-1 in EBSS + 0.1% BSA). Cells were co-
incubated with the extract throughout the assay. β-Hexosaminidase release and MTT assays 
were performed as in the assay with calcium ionophore. 
The effect of the extract on β-hexosaminidase release in the absence of stimuli (calcium 
ionophore or IgE/antigen) was simultaneously checked in every assay performed with an 
allergic stimulus. 
 
3.9.2. MTT reduction assay 
 
Cellular viability was assessed by the reduction of MTT to formazan, according to a 
previously described method (98), with some modifications. After cell treatment, culture 
medium removal and cells washing with DPBS, cells in 24-well plates were incubated with 1 
mL/well of MTT (0.5 mg mL-1), for 30 min at 37 ºC. Supernatant was then discarded, 
formazan was solubilized in DMSO (1 mL) and quantified by measurement of optical density 
at 550 nm, using a microplate reader. Results are expressed as percentage of control 
(without allergic stimulus). Three independent assays were performed in duplicate with 
calcium ionophore (or extract only) and six independent assays were performed in duplicate 
with IgE-DNP – DNP-BSA (or extract only). 
 
3.9.3. Quantification of released β-hexosaminidase 
 
To assess the effect of the extract in RBL-2H3 cells degranulation, β-hexosaminidase was 
quantified according to a previously published method (99), with some modifications. Briefly, 
30 μL of supernatant was incubated with 50 μL of 1.3 mg mL-1 4-nitrophenyl N-acetyl-β-D-
glucosaminide (in 0.2 M citric acid, pH 4.5), for 1 h at 37 ºC. β-Hexosaminidase reaction was 
stopped by the addition of 80 μL of NaOH 0.5 M and absorbance was measured at 405 nm 
using a microplate reader. Three independent assays were performed in duplicate in the 
assay with calcium ionophore (or extract only) and six independent assays were performed 
in duplicate in the assay with IgE-DNP – DNP-BSA (or extract only). 
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3.9.4. β-Hexosaminidase inhibitory activity 
 
Besides avoiding β-hexosaminidase release, the extract may directly inhibit β-
hexosaminidase enzymatic activity. The inhibition of β-hexosaminidase activity was checked 
by the following assay (99): after culture, cells were lysed by incubation with lysis buffer (50 
mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton X-100) for 1 h, at 0 ºC. Lysates were 
centrifuged at 8,000 x g for 5 min. The resulting supernatants were used to determine β-
hexosaminidase activity in the presence and in the absence of the extract, as described in 
the previous section. Three independent assays were performed in duplicate. 
 
3.9.5. Lipoxygenase inhibition assay 
 
The oxidation of linoleic acid, by lipoxygenase, to the conjugated diene 13-hydroperoxy 
linoleic acid was followed by measuring the absorbance at 234 nm on an UV/vis 
spectrophotometer (Helios Alpha, Cambridge, UK). The assay was performed by adding 20 
μL of extract dissolved in phosphate buffer (pH 9.0), 1 mL of phosphate buffer and 20 μL of a 
soybean lipoxygenase solution (500 U). After 5 min incubation, at room temperature, the 
reaction was started by the addition of 50 μL sodium linoleate (2 mM in ethanol). The 
reaction time was 3 min and the inhibition of the enzyme activity was calculated by 
comparing the reaction rate with the control (without extract) (99). 
 
3.10. Statistical analysis 
 
All statistical calculations were made using GraphPad Prism 5 Software (San Diego 
California, USA). For all cell-system assays, determination of the statistical significance in 
comparison to control was performed using the parametric method of one-way ANOVA on 
ranks, followed by Bonferroni’s post-hoc test in RAW 264.7 macrophages. Two-way ANOVA 
and Sidak’s multiple comparisons test were used to determine the interaction between 
extract and LPS in cell viability and differences in citrulline and NO release by LPS-
stimulated macrophages. 
 
Two-way ANOVA and Bonferroni’s test, as post-hoc test, were used to determine the 
interaction of the stimulus and the extract in MTT reduction assay in RBL-2H3 cells. Two-
tailed t paired test was used to determine the statistical significance in comparison to control 
in β-hexosaminidase release assay.  
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In all cases, p values lower than 0.05 were considered statistically significant. 
 
4. Acidified methanol extract and fractions 
 
4.1. Preparation 
 
Aliquots of 1 g of E. plantagineum bee pollen were accurately weighed, thoroughly mixed 
with 10 mL of methanol containing 0.5% HCl (v/v), ultra-sonicated for 1 h and centrifuged at 
4000 rpm during 10 min. The supernatant was decanted and the residue was re-extracted by 
vortexing for 2 min with 10 mL of methanol containing 0.5% HCl (v/v) and centrifuged at 4000 
rpm for 10 min. The supernatants were pooled together and the solvent was evaporated 
under reduced pressure at 30 ºC. In order to obtain extracts enriched in phenolic 
compounds, a SPE procedure was performed using Chromabond C18 non-end-capped 
(NEC) columns (45 µm particle size, 60 Å pore size; 10 g sorbent mass, 70 mLreservoir 
volume) from Macherey-Nagel (Düren, Germany). The residue was dissolved in 10 mL of 
water and applied to the SPE cartridge preconditioned with 20 mL of ethyl acetate, 20 mL of 
methanol and 20 mL of water. The loaded cartridge was washed with 10 mL of water. A 
fraction containing non-coloured phenolics was eluted with 100 mL of ethyl acetate (fraction 
I). A second fraction with anthocyanins (fraction II) was eluted with 40 mL of methanol. A 
combined extract was obtained by mixing ethyl acetate and methanol eluates (whole extract). 
The eluates were concentrated under reduced pressure, and the residues obtained were 
dissolved in 5 mL of methanol (final concentration of 200 mg mL-1). 
 
4.2. Acid hydrolysis 
 
One mL of HCl 2 M was added to 2 ml of fraction II. The acidic solution was heated at 100 
ºC for 30 min, under reflux. The obtained anthocyanins were recovered by SPE using 
Chromabond C18 NEC columns (45 µm particle size, 60 Å pore size; 1 g sorbent mass, 6 mL 
reservoir volume) from Macherey-Nagel (Düren, Germany), previously conditioned with 
methanol and HCl 2M. Compounds were eluted with 20 mL of methanol. The solvent was 
evaporated under reduced pressure at 30 ºC, the residue was dissolved in 2 mL of methanol, 
filtered through a 0.45 µm pore size filter and injected for anthocyanins identification. 
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4.3. HPLC-DAD analysis 
The extracts were analysed on an analytical HPLC unit (Gilson) equipped with a 
Spherisorb ODS2 column (25.0  0.46 cm, 5 µm, particle diameter). The data were 
processed on a Unipoint Software system (Gilson Medical Electronics, Villiers le Bel, 
France). Peak purity was checked by the software contrast facilities. 
 
4.3.1. Flavonols 
 
The extracts were analysed according to the method used for the analysis of the 
hydromethanol extract described in section 3.3. Spectral data from all peaks were 
accumulated in the range 200–600 nm, and chromatograms were recorded at 350 nm. 
Phenolic compounds quantification was achieved by the absorbance recorded at 350 nm 
relative to external standards. Because standards of all identified flavonoid derivatives were 
not commercially available, kaempferol derivatives were quantified as kaempferol-3-O-
rutinoside, except kaempferol-3-O-glucoside, which was quantified as itself. 
 
4.3.2. Anthocyanins 
 
Coloured phenolics were analysed following a previously described method (100). The 
mobile phase consisted of water/formic acid/acetonitrile (87:10:3, v/v/v; eluent A) and 
water/formic acid/acetonitrile (40:10:50, v/v/v; eluent B), using a gradient program as follows: 
from 10 to 25% B (10 min), from 25 to 31% B (5 min), from 31 to 40% B (5 min), from 40 to 
50% B (10 min), from 50 to 100% B (10 min) and from 100 to 10% B (5 min). The flow rate 
was 0.8 mL min-1 and the injection volume was 20 µL. Chromatograms were recorded at 500 
nm. Phenolic compounds in the extracts and in the hydrolysed extracts were identified by 
comparing their retention times and UV-Vis spectra with those of standards when 
commercially available and by comparison with literature (37). Quantification was performed 
at 500 nm. Delphinidin heterosides were quantified as delphinidin-3-O-glucoside, petunidin 
heterosides and malvidin-3-O-glucoside were quantified as malvidin-3-O-glucoside. 
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4.4. Effect on cell oxidative stress 
 
4.4.1. Cell culture conditions and treatments 
 
Human colorectal adenocarcinoma cell line (Caco-2) from the American Type Culture 
Collection (LGC Standards S.L.U., Spain) was grown in DMEM+GlutaMAXTM-I supplemented 
with 10% foetal bovine serum (FBS) heat-inactivated, 1% non-essential aminoacids, 1% 
fungizone and 6 µg mL-1 transferrin, 1% penicillin and 1% streptomycin, at 37 ºC in 5% CO2, 
until they reach 90% confluence. For cells treatment the culture medium was prepared 
without FCS. Cells were plated at 1.5×105 cells mL-1 using 200 µL/well of cell suspension in 
96-well plates (viability assays), 1200 µL/well in 24-well plates (GSH, DCFA-DA) and 2.5 
mL/well in 12-well plates (enzymes) and then incubated until they reached confluence. 
Just before the assays, an aliquot of the extracts was evaporated under a nitrogen 
stream, the residue was dissolved in the same volume of culture medium without FCS and 
sterilized by filtration through a 0.22 μm size pore membrane. A series of five dilutions was 
prepared and cells were exposed for 24 h to the different concentrations of the extracts. In 
order to evaluate the antioxidant potential, cells were pre-exposed for 24 h to the extracts, 
then the extracts were removed and cells were exposed to 150 µM of t-BHP for 4 (DCFA-DA 
assay) or 6 h (other assays). 
 
4.4.2. MTT reduction assay 
 
After cells treatment and removal of the culture medium, adherent cells were treated for 
30 min with 0.5 mg mL-1 of MTT. The formazan crystals were then dissolved with DMSO and 
quantified by measuring the absorbance at 560 nm in a microplate reader (98). Results are 
expressed as percentage of control. Five independent experiments were performed in 
triplicate. 
 
4.4.3. LDH leakage 
 
LDH was determined by adding pyruvate (124 µM) and NADH (154 µM) to the culture 
medium of treated cells and following the rate of oxidation of NADH at 340 nm during the 
conversion of pyruvate to lactate (98, 101). Results are expressed as percentage of control. 
Five independent experiments were performed in triplicate. 
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4.4.4. Reactive species 
 
The measurement of intracellular reactive species with DCFA-DA was performed using a 
previously described method with modifications (102). Cells were exposed to the extracts for 
24 h and the culture medium was removed. DCFA-DA (10 µM, dissolved in culture medium 
(DMEM) without phenol red) was added and the cells were incubated with the probe for 30 
min at 37 ºC. The probe was removed and t-BHP dissolved in culture medium without phenol 
red was added. Fluorescence (485 nm excitation, 528 nm emission) was read immediately 
and every 30 min during 4 h, in a microplate spectrofluorimeter (Synergy HT, Bio-Tek 
Instruments Winooski, USA, operated by KC4 software). The plate was maintained at 37 ºC 
between readings. Results are expressed as % of control (without t-BHP) and were 
normalized with the result at 0 time. Five independent assays were performed. 
 
4.4.5. Total glutathione 
 
Total glutathione (GSHt) was measured by DTNB-glutathione reductase recycling assay, 
according to a previously described method (103, 104). In brief, after cells treatment, the 
culture medium was removed and 250 µL of perchloric acid 5% were added to each well. 
Incubation was maintained during 10 min on ice in order to extract GSHt, then the solution 
was collected and kept at −20 ºC until analysis. 250 µL of NaOH 0.3 M were added to the 
cells in each well to solubilize proteins for protein quantification.  
GSH was measured by following the increase of 5-thio-2-nitrobenzoic acid (TNB) at 405 
nm, resulting from the oxidation of GSH by DTNB (1.28 mM). The assay was performed after 
neutralizing perchloric acid with KHCO3 0.76 M, in the presence of GR (2.0 U mL
-1) and 
NADPH (0.21 mM), to recycle GSSG, increasing the detection limit. Five independent assays 
were performed. 
 
4.4.6. Antioxidant enzymes 
 
For the measurement of enzymes activity, after exposure to the extracts the culture 
medium was collected for extracellular SOD analysis and the cells were lysed on ice for 30 
min with 1% Triton X-100 in Tris 50 mM pH=8.0, containing 150 mM NaCl, 0.5 mM PMSF 
and 1 mM DTT (for GPx analysis 0.5 mM of DTT was used). The lysates were centrifuged at 
10,000 rpm for 10 min at 4 ºC and the supernatants were collected for enzymatic and protein 
assays. Five independent assays were performed. 
 
Experimental Section 
 
59 
 
4.4.6.1. Glutathione-S- transferase 
 
Glutathione-S-transferase (GST) activity was assayed according to a previously described 
method (105). GSH (1 mM) was incubated at room temperature with CDNB (1.5 mM) and the 
formation of the conjugate was monitored at 340 nm. GST activity was calculated by using 
an extinction coefficient of 9.6 mM-1 cm-1. 
 
4.4.6.2. Glutathione reductase 
 
Glutathione reductase (GR) activity was determined at room temperature, following the 
decrease of NADPH (0.5 mM) at 340 nm, during the reduction of GSSG (1.2 mM) to GSH 
(106). GR activity was calculated by using an extinction coefficient of 6.22 mM-1 cm-1. 
 
4.4.6.3. Glutathione peroxidase 
 
Glutathione peroxidase (GPx) activity was determined following a previously described 
method (107). The activity was indirectly measured by a coupled assay of GSSG reduction, 
under conditions in which GPx activity is rate limiting. The assay was performed at room 
temperature using t-BHP (0.15 mM) as substrate, GSH (1 mM) plus NADPH (0.15 mM) and 
GR (0.03 U mL -1) to recycle the formed GSSG. The decrease of NADPH was measured at 
340 nm. The enzyme activity was calculated by using an extinction coefficient of 6.22 mM-1 
cm-1 and expressed as mmol of NADPH oxidized/min/mg of protein. 
 
4.4.6.4. Catalase 
 
Catalase activity was measured at room temperature by monitoring the decomposition of 
H2O2 (10 mM) at 240 nm (107). The enzyme activity was calculated by using an extinction 
coefficient of 39.4 M-1 cm-1.  
 
4.4.6.5. Superoxide dismutase 
 
Extracellular SOD was assayed using a previously described method (107) with 
modifications. A PMS (0.003 mM) / NADH (0.07mM) system was used to generate O2
•- and 
subsequent reduction of NBT (0.03 mM) by O2
•- was monitored at 560 nm. SOD activity was 
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determined by interpolation in a calibration curve, built under the same conditions with bovine 
SOD in the concentration range of 0.025- 0.25 U mL-1. 
In order to screen for O2
•- scavenging activity, an assay was performed by incubating 
culture medium without cells, and measuring NBT reduction in the previously described 
conditions. Four independent assays were performed. The results are expressed as % of 
control and compared with the ones obtained in the assay performed with cells. 
 
4.4.7. Protein quantification 
 
 Protein quantification was performed according to the Bradford method (108). Proteins 
were measured by addition of 200 mL of Bradford dye reagent (brilliant blue G, 0.1 mg mL-1; 
ethanol, 5% (v/v); phosphoric acid, 10 % (v/v); water) to 40 mL of the acidified extract or 
fractions I and II, pre-diluted 100 times. The photometrical measure was performed at 595 
nm. Bovine serum albumin was used to generate a standard curve (34). 
 
4.5. Statistical analysis 
 
All statistical calculations were made using Graphpad Prism 6 Software (San Diego, CA, 
USA). For all cell systems assays, the statistical significance in comparison to control was 
estimated using the parametric method of two-way ANOVA, followed by Dunnets's test (LDH, 
MTT, DCFA-DA and antioxidant enzymes) or Sidak’s (GSHt, superoxide), as post-hoc test. 
Two-way ANOVA and Sidak’s multiple comparisons test were used to compare between 
groups. 
In all cases, p values lower than 0.05 were considered statistically significant. 
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1. Hydromethanol extract 
 
 
1.1. Chemical composition 
 
As referred above, pollen from Echium species are described to be a potential source 
of pyrrolizidine alkaloids, a class of secondary metabolites with hepatotoxic properties. 
The presence of alkaloids in E. plantagineum bee pollen hydromethanolic extract was 
screened by the general alkaloids precipitation tests (Dragendorff’s, Mayers’s and 
Bertrand’s), giving negative results. 
 
1.1.1. Phenolic profile 
 
The phenolic profile of E. plantagineum bee pollen hydromethanolic extract was 
established by HPLC-DAD (Figure 15). The chromatogram showed kaempferol-3-O-
neohesperidoside (4) as a major peak, followed by its acylated derivative, kaempferol-3-
O-(3’/4’-acetyl)-neohesperidoside (6), and eight minor peaks, comprising both quercetin 
and kaempferol derivatives. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. HPLC-DAD chromatogram (350 nm) of phenolic compounds in E. 
plantagineum bee pollen hydromethanolic extract and chemical structure of the main 
compound, kaempferol-3-O-neohesperidoside (4). Other compounds: (1) quercetin-3-O-
neohesperidoside; (2) kaempferol-3-O-sophoroside; (3) kaempferol-3-O-(3’/4’-rhamnosyl) 
neohesperidoside; (5) kaempferol-3-O-neohesperidoside derivative; (6) kaempferol-3-O-
(3’/4’-acetyl)neohesperidoside; (7) kaempferol-3-O-neohesperidoside-7-O-rhamnoside; (8) 
kaempferol-3-O-glucoside; (9) kaempferol-3-O-rutinoside and (10) kaempferol-3-O-(3’/4’-
acetyl)-neohesperidoside isomer. 
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The content of compounds 4 and 6 was ca. 9 and 3 g kg-1, respectively. The other 
phenolics accounted together for 0.4 g kg-1 (Table 3). 
 
Table 3. Phenolic compounds content in E. plantagineum bee pollen hydromethanol 
extract. 
Phenolic compounds mg kg-1 (Dry pollen)a 
1 Quercetin-3-O-neohesperidoside 24.8 + 0.1 
2+3 Kaempferol-3-O-sophoroside + kaempferol-3-O-(4’’-
rhamnosyl)-neohesperidoside 
120.9 + 0.1 
4 Kaempferol-3-O-neohesperidoside 8864.1 + 14.3 
5 Kaempferol-3-O-neohesperidoside derivative 25.8 + 0.6 
6 Kaempferol-3-O-(3’/4’-acetyl)-neohesperidoside 2988.1 + 10.0 
7 Kaempferol-3-O-neohesperidoside-7-O-rhamnoside 20.7 + 0.7 
8 Kaempferol-3-O-glucoside 15.1 + 0.1 
9+10 Kaempferol-3-O-rutinoside + kaempferol-3-O-(3’/4’-acetyl)-
neohesperidoside isomer 
213.6 + 2.1 
Total 12273.2 
a Values are expressed as mean ± standard deviation of three determinations.  
 
 
1.1.2. Organic acids profile 
Eight organic acids were identified in E. plantagineum bee pollen hydromethanol 
extract: oxalic, aconitic, citric, pyruvic, malonic, shikimic, acetic and fumaric acids (Figure 
16). 
The sum of the determined organic acids was ca. 10 g kg-1 (Table 4), malonic acid (5) 
being the main compound (ca. 80% of total identified organic acids). Fumaric acid (8) was 
the minor compound (ca. 0.005% of the total acids). 
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Figure 16. HPLC-UV organic acids profile of E. plantagineum hydromethanol extract. 
Detection at 214 nm. Compounds: oxalic acid (1), aconitic acid (2a+2b), citric acid (3), 
pyruvic acid (4), malonic acid (5), shikimic acid (6), acetic acid (7) and fumaric acid (8).   
 
 
Table 4. Organic acids content of E. plantagineum bee pollen hydromethanol extract. 
Organic acid mg kg-1 (Dry pollen)a 
1 Oxalic 51.05 ± 0.98 
2a + 2b Aconitic 6.89 ± 0.26 
3 Citric 10.24 ± 0.05 
4 Pyruvic 890.27 ± 0.85 
5 Malonic 8152.87 ± 0.37 
6 Shikimic 2.20 ± 0.43 
7 Acetic 1132.02 ± 111.33 
8 Fumaric 0.48 ± 0.02 
Total 10245.54 ± 114.29 
 
a Results are expressed as mean ± standard deviation of three determinations. 
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1.1.3. Fatty acids profile 
 
 
Five fatty acids were determined in E. plantagineum bee pollen hydromethanol extract 
after purification, performed in order to protect the equipment and facilitate identification 
(Figure 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. GC-IT/MS fatty acids profile of E. plantagineum hydromethanol extract. All 
compounds correspond to their trimethylsilyl (TMS) derivatives: capric acid (1), lauric acid 
(2), palmitic acid (3), α-linoleic acid (4) and stearic acid (5).   
 
 
The fatty acids content was ca. 690 mg kg-1, palmitic acid being the major compound 
(ca. 57%), followed by α-linolenic acid, which represented ca. 27% of the identified 
compounds (Table 5). 
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Table 5. Fatty acid content of E. plantagineum bee pollen hydromethanol extract. 
 
 
 
 
 
 
 
a Results are expressed as mean ± standard deviation of three determinations 
 
Although the fatty acids profile of bee pollen hydromethanol extract is different from the 
ones previously described in E. plantagineum seeds (109) and leaves (61) oils, α-linolenic 
acid is a representative fatty acid in all plant materials. 
 
1.2. Biological effects 
 
Inflammation is a protective immunovascular response against harmful stimuli. As it is 
a defence mechanism, it manifests in most of the diseases, like allergic and infectious 
diseases. In this sense, the hydromethanol extract of E. plantagineum was studied as to 
determine its antioxidant potential, anti-inflammatory, anti-bacterial and anti-allergic effect. 
 
1.2.1. Reactive species scavenging in cell-free systems 
 
Before testing in macrophages, the hydromethanol extract of E. plantagineum bee 
pollen was screened for antioxidant activity against NO and O2
- in cell-free systems. The 
extract scavenged the sodium nitroprusside-generated NO in a concentration dependent 
manner (IC25 = 1.9 mg mL
-1) (Figure 18).  
  
Fatty Acid mg kg-1(Dry Pollen)a 
1 Capric (C10:0) 53.0 ± 1.7 
2 Lauric (C12:0) 27.1 ± 2.6 
3 Palmitic (C16:0) 391.6 ± 19.3 
4 α-Linolenic (C18:3) 183.9 ± 18.6 
5 Stearic (C18:0) 34.8 ± 2.8 
Total 690.4 ± 45.0 
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Figure 18. Effect of E. plantagineum bee pollen hydromethanol extract against •NO and 
O2
•- in cell-free systems. Results expressed as mean ± SEM of three independent 
experiments performed in triplicate.  
However, a dual behaviour was seen against O2
- generated by the PMS/NADH 
system: until 0.8 mg mL-1 a dose-dependent scavenging effect was observed, but a pro-
oxidant response was noticed with higher concentrations, the compounds present 
seeming to participate in the formation of O2
- (Figure 18). 
The direct interaction of the compounds present in the extract with NBT was excluded, 
because the reduction of NBT to formazan did not occur when the assay was performed 
in the absence of PMS and NADH. Furthermore, we can also assume that the superoxide 
is not generated by the direct oxidation of kaempferol derivatives by molecular oxygen. 
So, the apparent pro-oxidant behaviour at higher extract concentrations observed in this 
system for evaluating O2
- scavenging potential can be without biological significance, 
since PMS and NBT are not endogenous molecules. Nevertheless a pro-oxidant 
behaviour has been previously observed with flavonoids and flavonoid-rich extracts (110, 
111). 
 
1.2.2. Effect on inflammation 
 
The cellular model of LPS-stimulated macrophages is widely used to assess anti-
inflammatory activity (68, 69, 112). It is well known that infection of cells by 
microorganisms activates the inflammatory response due to the recognition by 
macrophages receptors of LPS present in microorganisms’ cell wall: the initial sensing of 
infection is mediated by innate pattern recognition receptors that are expressed by 
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macrophages dendritic cells and various nonprofessional immune cells. Although 
inflammation is a protective response of the body to ensure removal of detrimental stimuli, 
as well as a healing process for repairing damaged tissue, the stimulation of 
macrophages, initiated by microorganisms (or other agent) can result in the 
overproduction of inflammatory mediators like PGE2 and PGI2, which enhance edema 
formation and leukocyte infiltration by promoting blood flow in the inflamed region. This 
process can be at the origin of inflammatory diseases like type 2 diabetes, atherosclerosis 
and Alzheimer’s disease (72). 
 
1.2.2.1. Effect on cell viability 
 
The extract was not cytotoxic until 8.3 mg mL-1 (equivalent to 172 mM of kaempferol 
and quercetin derivatives). The exposure to 16.7 mg mL-1 for 19 h induced a significant 
decrease in cell viability (p<0.01), as assessed by the MTT assay. The cellular viability 
was further decreased by the extract at 33.3 mg mL-1, being statistically significant in both 
LDH and MTT assays (p<0.001) (Figure 20). 
 
Cell treatment with 1 mg mL-1 LPS did not significantly alter cell viability and the results 
obtained with cells exposed to extract and LPS were similar to the ones found with cells 
exposed only to the extract (p<0.05) (Figure 19). In fact, for the concentration of 8.33 mg 
mL-1 an increase in viability was shown (p<0.01). 
 
 
 
 
 
 
 
 
Figure 19. Effect of E. plantagineum bee pollen extract in cell viability. RAW 264.7 
macrophages were pre-exposed to the extract for 1 h followed by 18 h co-exposition with 
1 mg mL-1 of LPS. Cell viability was assessed by MTT reduction and LDH release assays. 
Values show mean ± SEM of five independent assays performed in duplicate. *p<0.05; 
**p<0.01; ***p<0.001, compared to the respective control; ##p<0.01 LPS- exposed cells 
compared with cells exposed only to the respective extract concentration.  
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1.2.2.2. •NO and L-citrulline in culture medium 
 
The levels of •NO and L-citrulline in the culture medium of LPS stimulated cells (T 
group) after 18 h exposure were 11.8±1.7 and 10.8±0.9 μM, respectively. The levels of 
these metabolites in the C group were below the quantification limit. E. plantagineum bee 
pollen hydromethanol extract at non-toxic concentrations dose-dependently decreased 
•NO in the culture medium of LPS-stimulated cells (p<0.001) (Figure 20). Accordingly, the 
formation of L-citrulline was also inhibited by the extract at all concentrations, being 
significant for concentrations higher than 1.0 mg mL-1 (p<0.001) (Figure 20). 
 
 
 
 
 
 
 
 
 
 
Figure 20 Effect of E. plantagineum bee pollen extract pre-exposure in •NO and L-
citrulline production by LPS-stimulated macrophages. RAW 264.7 macrophages were pre-
exposed to the extract for 1 h followed by 18 h co-exposition with 1 mg mL-1 of LPS (T-
group). Extract concentrations: T0: 0; T1: 0.5 mg mL-1; T2: 1.0 mg mL-1; T3: 2.1 mg mL-1; 
T4: 4.2 mg mL-1; T5: 8.3 mg mL-1. Values show mean 6 SEM of five independent assays 
performed in duplicate. ***p<0.001, compared to LPS-only exposed cells.  
 
In relation to •NO, LPS induces its production by iNOS accompanied by L-citrulline 
formation in stoichiometric amounts (113). Accordingly, the decrease of the radical was 
paralleled by the decrease of L-citrulline in the culture medium of LPS-stimulated 
macrophages exposed to the extract (Figure 20). Given these results, we can state that 
the extract inhibits iNOS induction by LPS. 
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1.2.2.3. Effect on eicosanoids  
 
Besides NO, LPS-stimulated macrophages produce PGs as a consequence of COX-2 
up-regulation. Attending to the evanescence of primary PGs, we proceeded to the 
measurement of some metabolites by UPLC-MS. As isoprostanes (IsoPs) suffer 
glucuronidation (97, 114) and UDP-glucuronosyltransferases are present in macrophages 
(115), an hydrolysis step was included in the eicosanoids extraction protocol to ensure 
that all eicosanoids found in the macrophages lysate and/or cell culture supernatants were 
totally determined by UPLC-MS and to avoid underestimations of their concentrations (96, 
97). 
The levels of prostaglandins and IsoPs were measured in RAW macrophages whole-
cell lysate, under mild conditions (Figure 21). Two prostaglandins (PGE2 and 11β-
PGF2α) were quantified both in control cells and in cells exposed to LPS, but higher levels 
were observed in the latter (Figure 21A). The levels of PGE2 (about 1 ng mL-1) in non-
stimulated cells were not significantly affected by bee pollen extract. The increased levels 
of PGE2 in LPS-stimulated cells were reduced by the extract at 0.5 and 1 mg mL-1 
(p<0.01), but for higher concentrations the results were not significantly different from 
those of cells only exposed to LPS (Figure 21A). 
In what concerns to 11β-PGF2α, the extract showed a tendency to increase the levels 
of this PGD2 metabolite in control cells. In LPS exposed cells the levels of 11β-PGF2α 
were dose-dependently decreased by the extract at 0.5 and 1 mg mL-1, but raised for 
higher concentrations, being similar to that found in LPS-only exposed cells for the highest 
concentration tested (Figure 21A). 
Besides prostaglandins, three IsoPs (8-iso-15(R)-PGF2α, 8-iso-15-keto-PGF2α and 8-
iso-PGF2α) were quantified in the cellular lysate (Figure 21B). Their contents in control 
cells were increased by the extract. LPS itself raised the levels of isoprostanes inside the 
cell and, in general, bee pollen extract decreased IsoPs below the basal level at 1 mg mL-
1. Higher extract concentrations raised IsoPs levels (Figure 21B).  
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Figure 21. Effect of E. plantagineum bee pollen extract pre-exposure in intracellular 
eicosanoids levels of LPS-stimulated macrophages. Eicosanoids were determined in the 
whole cell extracts of RAW 264.7 macrophages pre-exposed to the extract for 1 h, 
followed by 8 h co-exposition with 1 mg mL-1 of LPS. C group: control group exposed to 
extract only. T group: extract and LPS co-exposed group. Extract concentrations: C0 and 
T0: 0; C1 and T1: 0.5 mg mL-1; C2 and T2: 1.0 mg mL-1; C3 and T3: 2.1 mg mL-1; C4 and 
T4: 4.2 mg mL-1; C5 and T5: 8.3 mg mL-1. Values show mean ± SEM of two independent 
experiments performed in triplicate. (A) Prostaglandin and prostaglandin metabolites. (B) 
Isoprostanes. *p<0.05; **p<0.01 compared to the respective control (with or without LPS).  
 
 
The action of COX-2 on AA leads to the formation of PGH2, the substrate for the 
various PG synthases (Figure 22). In vivo studies have shown that COX-2 inhibitors 
reduce PGE2 more profoundly than other PGs (116). PGE2 was the prostaglandin with 
the highest increase in the whole cell lysate of LPS-stimulated macrophages (Figure 21). 
The selective increase of this PG in LPS-stimulated rat macrophages is probably due to 
the up-regulation of PGE2 synthase in concert with COX-2 (117, 118). 
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Figure 22. Metabolic pathways of eicosanoids determined in LPS-stimulated 
macrophages pre-exposed to E. plantagineum bee pollen extract. AA, arachidonic acid; 
COX, cyclooxygenase; Cyp 450, Cyt P450 enzyme; DGLA, dihomo-c- linolenic acid; PG, 
prostaglandin; PGS, PG synthase.  
 
 
Additionally, the eicosanoids profile in the culture medium of RAW 264.7 macrophages 
was also established (Figure 23). Two prostaglandins (PGE1 and PGE2) and three 
prostaglandins metabolites (6-keto-PGF1α, 20-hydroxy PGE2 and 11β-PGF2α) were 
determined (Figure 23A). PGE1 release to the medium was increased by LPS exposure 
and the extract at all concentrations tested was able to decrease the levels of this PG. 
PGE1 returned to the levels observed in the culture medium of non-stimulated cells, for 
extract concentrations higher than 0.5 mg mL-1 (Figure 23A). 
Also PGE2 release was highly increased by LPS exposure (Figure 23A). Although this 
prostaglandin was also measured in non-stimulated cells, a 20 fold increase was 
observed after 8 hours exposure to LPS. The extract decreased PGE2 release into the 
medium at 1 mg mL-1 in control cells and at 0.5 mg mL-1 in LPS exposed cells. For higher 
extract concentrations the levels of PGE2 in the T group were higher than the ones found 
in LPS-only exposed cells (p<0.05). On the other hand, considerable amounts of 20-
hydroxy PGE2 were found only in the medium of LPS exposed cells and LPS plus extract 
at 0.5 mg mL-1 
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and 1 mg mL-1. A similar behaviour was observed for 6-keto-PGF1α, a PGI2 metabolite 
that was only quantified in the medium of LPS exposed cells and LPS plus extract at 0.5 
mg mL-1. 
Considering 11β-PGF2α, the amount of this PG metabolite was higher in the culture 
medium of non-stimulated cells, compared to LPS-stimulated cells. Particularly in LPS-
stimulated RAW macrophages, the extract did not have a significant effect on the release 
of 11β-PGF2α, except when at 2.1 mg mL-1. 
In what concerns to IsoPs, it was observed that both 8-iso-15(R)-PGF2α and 8-iso-15-
keto-PGF2α increased with LPS exposure, while the levels of 8-iso-PGF2α decreased 
(Figure 23B). The effect in the former IsoPs was significantly reduced by the extract only 
at the lowest concentration tested (p<0.05). However, in control cells, the extract at 0.5 
mg mL-1 significantly increased the levels of 8-iso-15(R)-PGF2α, 8-iso-15-keto-PGF2α, as 
well as that of the prostaglandin metabolite 11β-PGF2α. 
Regarding 8-iso-PGF2α, the extract at 1 mg mL-1 further decreased its level in LPS-
exposed cells. 
Although PGF2α has been implicated in acute inflammation, in this model of 
inflammation, tetranor-PGFM, which is PGF2α main metabolite, was not detected, neither 
in whole cell extract nor in the culture medium. 
U-44069, an analogue of PGH2, thromboxane A2 (as its stable analogue U-46619) and 
11-dehydrothromboxane B2 were not encountered in whole cell lysates or culture medium 
of macrophages. 
The search for 2,3-dinor-6-keto-PGF1α (a PGI2 metabolite) and the IsoP 2,3-dinor-8-
iso-PGF2α in the cell lysate and culture medium gave negative results. 
Comparing the levels of eicosanoids in the culture medium and inside the cell (Figures 
21 and 23A and 23B) it can be observed that eicosanoids are mainly secreted into the 
medium, with the exception of 11β-PGF2α and 8-iso-PGF2α that are present at similar 
levels inside and outside the cell. 
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Figure 23. Effect of E. plantagineum bee pollen extract pre-exposure in eicosanoids 
release of LPS-stimulated macrophages. Eicosanoids were determined in the culture 
media of RAW 264.7 macrophages pre-exposed to the extract for 1 h followed by 8 h co-
exposition with 1 mg mL-1 of LPS. C group: control group exposed to extract only. T group: 
extract and LPS co-exposed group. Extract concentrations: C0 and T0: 0; C1 and T1: 0.5 
mg mL-1; C2 and T2: 1.0 mg mL-1; C3 and T3: 2.1 mg mL-1; C4 and T4: 4.2 mg mL-1; C5 
and T5: 8.3 mg mL-1. Values show mean ± SEM of two independent assays experiments 
performed in triplicate. (A) Prostaglandin and prostaglandin metabolites. (B) Isoprostanes. 
*p<0.05; **p<0.01 compared to the respective control (with or without LPS).  
 
PGE2 undergoes hydroxylation at C-20 catalysed by Cyt P450 enzymes, originating 
20-hydroxy PGE2 (119). This PGE2 metabolite was released to the culture medium of 
macrophages in response to LPS stimulation, but the extract at concentrations higher than 
1 mg mL-1 decreased the release of 20-hydroxy PGE2 below the quantification limits, as 
observed in the culture medium of non-exposed cells (Figure 23). Therefore, the extract 
at 1 mg mL-1 was able to neutralize the toxic effect exerted by LPS. This result can be 
attributed to the known inhibition of Cyt P450 enzymes by flavonoids (120). In opposition, 
the effect of the extract on PGE2 was not so pronounced, being more effective at lower 
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concentrations (Figures 21 and 23). Tetranor-PGEM and tetranor-PGAM, PGE2 
metabolites (121), were not detected. 
PGE1, a PG derived from dihomo-c-linolenic acid (Figure 22), was found in the culture 
medium of LPS stimulated macrophages. The extract was more effective in decreasing 
the release of PGE1 than of PGE2 (Figure 23). 
As said above, another prostanoid found in the culture medium of cells exposed to LPS 
was 6-keto PGF1α, a PGI2 metabolite (Figure 23). PGI2 formation is mediated by 
prostacyclin synthase, a member of the Cyt P450 monooxygenase family. PGI2 is readily 
hydrolysed to form the stable 6-keto PGF1α (121). Interestingly, cells treated with the 
lowest extract concentration did not significantly alter the concentration of this metabolite, 
although for all the other extract concentrations 6-keto PGF1α levels were below 
quantification limits. So, it is possible that the phenolic compounds present in the extract 
exert an inhibitory effect on prostacyclin synthase, under inflammatory conditions, as seen 
for the inducible form of NOS. 
Thromboxane A2 biosynthesis is also catalysed by a member of the Cyt P450 enzymes 
and it counteracts PGI2 action (121). The absence of thromboxane A2 and its metabolite 
could be expected, since thromboxane A2 formation is mediated by COX- 1, although in 
LPS-stimulated cells COX-2 can also be involved (117). 
 
PGD2 has important roles in the mediation and resolution of inflammation. This PG is 
converted to several metabolites, including 11β-PGF2α, which maintains the biological 
activity of PGE2 (122). 11β-PGF2α was quantified in the cellular lysate and culture 
medium of control and LPS-exposed cells (Figures 21 and 23). The increase of PGE2 in 
the culture medium of LPS-stimulated macrophages compared to control group was 
accompanied by a decrease of 11β-PGF2α (Figure 23). PGD2 is a structural isomer of 
PGE2, and this can explain the opposite tendency observed for this prostanoid. In 
unstimulated macrophages PGD2 generation is coupled to the constitutive COX-1 (117). 
So, the decrease of 11β-PGF2α in the culture medium of LPS-stimulated cells when 
compared to control cells can be justified by the preferred production of PGE2, which is in 
agreement with bibliography (117). This fact can also explain why the extract had no 
effect in the release of 11β-PGF2α into the medium, since phenolic compounds mainly 
affect COX-2 (123). However, the intracellular level of 11β- PGF2α was increased by LPS 
and a decrease of this metabolite was observed when cells were also exposed to the 
extract (except for the highest concentration) in comparison with cells exposed only to 
LPS (Figure 21). 
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As previously said, the bee pollen extract used in this work was characterized by the 
presence of kaempferol and quercetin derivatives. It is well known that kaempferol inhibits 
iNOS, COX-2 expression and PGE2 formation in LPS-activated RAW macrophages (124). 
Also quercetin was found to decrease PGE2 in the culture medium of LPS-stimulated 
RAW macrophages (125), the reduction being much stronger in J774A.1 macrophages 
(126).   
 
The iNOS inhibitory activity of flavonoids is attributed to the inhibition of NF-kB 
induction (124). The more active flavonoids possess a double bond between C-2 and C-3 
and a 5,7-dihydroxyl group. The hydroxyl group at C-3 decreases the inhibitory potency 
(93). On the other hand, COX-2 inhibition by flavonoids is less studied, but is also partly 
attributed to NF-kB inhibition. NFkB is involved in COX-2 protein expression in LPS-
stimulated J774.1 macrophages and the exposition of these cells to NF-kB inhibitors 
before LPS challenge abrogates the generation PGE2 and 6-keto PGF1α (125). In fact, 6-
keto PGF1α release was inhibited by the extract, except for the lowest concentration 
tested, while a decrease of PGE2 release was only observed for this concentration 
(Figure 23). 
 
It can be expected polyphenol aglycones to be more potent than their heterosides. For 
instance, Kim and collaborators showed that isoliquiritigenin was significantly more active 
than its 4-O-glucoside (isoliquiritin) in reducing NO and PGE2 production, as well as 
protein and mRNA expression of iNOS and COX-2 (126). This result was explained by the 
different lipophilicity, which affects the cellular uptake and compatibility with cellular 
membranes (126). Also the inhibition of iNOS and COX-2 expression by quercetin was 
higher than the one of its 3-O-rutinoside, rutin (125). Nevertheless, the decrease of PG 
observed when cells were exposed to the extract at 0.5 or 0.1 mg mL-1 is probably due to 
the inhibitory action of the flavonol heterosides that characterize the bee pollen extract. 
It has been suggested a cross-talk between NOS and COX enzymes (127). NO may 
act through generation of peroxynitrite as the endogenous oxidant needed to create the 
tyrosyl radical required for catalytic activity of COX enzymes. NO exerts divergent effects 
on constitutive and inducible COX isoforms, activating COX-1, but inactivating COX-2 
(127). This may explain why extract concentrations that reduce NO to lower levels failed 
to reduce the levels of PGE2, the major PG released by LPS stimulated macrophages 
(Figures 21 and 23). 
 
Conversely, PGE2 demonstrated to modulate NO pathway in LPS-stimulated 
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macrophages (128). These results were not confirmed by Swierkosz and collaborators, 
who found that the formation of COX metabolites had no effect on NOS activity, whereas 
NO  inhibits both COX-2 activity and induction (129). 
 
IsoPs are derived from the free radical-catalysed peroxidation of AA in a COX 
independent mechanism (Figure 22). Due to the lack of enzymatic control, a series of 
stereoisomers can be formed (122). IsoPs are reliable markers of lipid peroxidation in vivo 
and potentially mediate some of the adverse effects of oxidant injury (130). In this study 
three IsoPs of the 8-series (containing the nonprostane hydroxyl group at C-8) were 
encountered, both in the cell lysate and in the culture medium (Figures 21 and 23). In 
general, LPS treatment leads to an increase of IsoPS, which can be a consequence of the 
increase of NO in LPS-exposed macrophages. The excess of NO production can lead to 
peroxynitrite formation, which is associated with increased IsoP generation in vitro and in 
vivo (131, 132). 
8-iso-PGF2α showed a different behaviour, since the release of this IsoP into the 
culture medium after 8 h exposition to LPS decreased when compared with control cells 
(Figure 23). 8-iso-PGF2α can be formed via COX-2 in monocytes and, as so, it was 
expected to increase under a pro-inflammatory stimulus (133). Nevertheless, at this time 
the level of 8-iso-PGF2α in cell lysate of LPS stimulated cells was higher than in control 
cells (Figure 21). 
IsoPs levels showed a tendency to be increased by extract concentrations above 1 mg 
mL-1, despite the decrease of NO contents (Figures 20, 21 and 23). This can be 
attributed to a pro-oxidant behaviour of phenolic compounds when present at high 
concentrations (observed in the O2
- cell-free assay), despite the ability of these 
compounds to inhibit iNOS induction in macrophages under an inflammatory stimulus 
(125, 126). 
 
1.2.3. Effect on degranulation  
  
In this study we used a crude extract to evaluate the anti-allergic potential of E. 
plantagineum bee pollen since bee pollen is consumed in folk and complementary 
medicines as a whole (134). So the extraction method used allowed the recovery of a 
wide variety of compounds, in order to guarantee that the compounds that have an activity 
in vivo were not lost during the extraction process.  
The extract revealed to be composed by several organic and fatty acids, as shown in 
tables 4 and 5, respectively. These compounds could affect the results of degranulation 
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since degranulation phenomenon is influenced by pH (135). However, as the pH range of 
the medium used in the assays was buffered to pH 6.8–7.2, the amounts of acids in the 
extracts were not sufficient to exceed the buffering capacity of the culture medium and so 
degranulation was not affected. 
 
1.2.3.1. Effect on cell viability 
 
First, the effects of the hydromethanol extract on cellular viability were evaluated by the 
MTT reduction assay. As it can be seen in Figure 24, the extract was not cytotoxic to 
RBL-2H3 cells in the range of concentrations used to evaluate its anti-allergic potential 
(0.52 to 2.08 mg mL-1). The extract by itself did not affect cell viability till the concentration 
of 8.33 mg mL-1 (data not shown). However, basophils pre-exposed to the hydromethanol 
extract for 15 min followed by co-exposition for 30 min with calcium ionophore (500 ng mL-
1) suffered a significant decrease of viability for concentrations above 4.17 mg mL-1 (data 
not shown). So, as ionophore A23187 is highly selective for calcium (136) it can be 
assumed that the interaction of the compounds present in the extract with the calcium 
ionophore leads to cellular calcium overload, compromising cellular viability for the higher 
extract concentrations tested. 
MTT reduction assay was also performed for RBL-2H3 cells treated with IgE/antigen in 
the presence and in the absence of the extract. The IgE/antigen treatment by itself did not 
affect basophils viability, either in the presence or absence of the extract (Figure 24B). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Effect of E. plantagineum bee pollen extract in RBL-2H3 basophils viability, 
assessed by MTT reduction assay. Values show mean ± SEM of three independent 
assays performed in duplicate with calcium ionophore (or extract only) and six 
independent assays performed in duplicate with IgE-DNP – DNP-BSA (or extract only). 
(A) Cells were pre-exposed to the extract for 15 min, followed by 30 min co-exposure to 
500 ng mL-1 calcium ionophore A23187; (B) Cells were pre-exposed to 100 ng mL-1 anti-
DNP IgE for 16 h, followed by 1 h extract co-exposure to 100 ng mL-1 DNP-BSA. 
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1.2.3.2. Effect on β-hexosaminidase release 
 
The release of β-hexosaminidase enzyme, a marker of degranulation in mast cells and 
basophils, allows estimating the anti-allergic potential of new drugs in vitro (83). In a first 
approach we used calcium ionophore A23187 to elicit degranulation of RBL-2H3 cells. 
Artificial activation of basophils by calcium ionophore A23187 is routinely used in the 
research of exocytosis to bypass the molecular events that are associated with the 
excitation of FcεRI receptors. With this stimulus the extract inhibited β-hexosaminidase 
release in a dose-dependent manner (p<0.001) (Figure 25A). Additionally, β-
hexosaminidase release was further investigated using higher extract concentrations. It 
was observed that the extract decreased β-hexosaminidase release at 4.17 mg mL-1 
(64.42% ± 2.55%, p<0.001), but at this concentration the cellular viability was significantly 
affected (data not shown). The subsequent increase of β-hexosaminidase release at 8.33 
mg mL-1 (90.98% ± 6.58%) may result not only from cell degranulation, but also from 
enzyme leakage by unviable cells with disrupted membrane integrity (137). 
 
 
 
 
 
 
 
 
 
 
Figure 25. Effect of E. plantagineum bee pollen extract in β-hexosaminidase release. 
Values show mean ± SEM of three independent assays performed in duplicate with 
calcium ionophore stimulus and six independent assays performed in duplicate using IgE-
DNP – DNP-BSA stimulus. (A) % of β-hexosaminidase release after RBL-2H3 exposure 
to ionophore; *** p<0.001. (B) % of β-hexosaminidase release after RBL-2H3 pre-
exposure to anti-DNP IgE, followed by DNP-BSA exposure; * p<0.05; ** p<0.01. 
  
The anti-allergic potential of the extract was also evaluated using IgE/antigen stimulus, 
since basophils possess high-affinity IgE receptors. As referred above, the cross-linking of 
FcεRI-bound IgE by allergens plays a pivotal role in IgE-mediated allergy (138). Using this 
allergic stimulus the co-exposition with the extract significantly inhibited the DNP-BSA-
induced β-hexosaminidase secretion in IgE-sensitized RBL-2H3 cells at 1.04 and 2.08 mg 
mL-1 (23.61% ± 8.15%, p<0.01, and 22.84% ± 11.57%, p<0.05, respectively) (Figure 
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25B). As observed with the calcium ionophore, when higher concentrations of the extract 
were assayed, an increase in β-hexosaminidase release was observed (data not shown). 
However, with this stimulus there was no observable decrease of cell viability. So, we can 
argue that at higher concentrations the extract demonstrated a potential allergic effect in 
IgE sensitized basophils. In fact, the hydromethanol extract has demonstrated a pro-
oxidant potential at these same concentrations, as mentioned in section 1.2.1. .Thus, it 
may be speculated that the generation of reactive oxygen species influenced the signaling 
pathways evoked by the IgE/antigen stimulus, leading to enhanced degranulation. This 
behaviour has already been observed for compounds with pro-oxidant activity (139). 
 
The anti-allergic potential demonstrated by the extract can be attributed to several 
compounds, namely to the polyphenols shown in table 3 and to the fatty acids displayed 
in table 5. Palmitic and α-linolenic acids, the two major fatty acids identified in the extract, 
have known anti-allergic effects. In fact, among the fatty acids found in the extract, α-
linolenic acid has been demonstrated to reduce the release of inflammatory mediators, 
including histamine and prostaglandin E2 (140). Moreover, epidemiological studies show 
that high intake of α-linolenic and palmitic acids during pregnancy may decrease the risk 
of asthma of the offspring (141). So, the anti-degranulation effects observed in the model 
used in the present study can result partially from the presence of fatty acids in the 
extract. 
Concerning to polyphenols, these compounds are well known for their anti-allergic 
potential (141). In fact, the tested extract contains derivatives of quercetin and kaempferol 
(Table 3), which have inhibitory effect on degranulation of mast cells and basophils (142). 
This effect is thought to result from two mechanisms: one by which polyphenols impact 
allergen-IgE complex formation, and another through which they impact on the binding of 
this complex to their basophil FcεRI (142). This can be explained by the formation of 
insoluble complexes between the polyphenols and potential allergenic proteins, rendering 
them to be hypoallergenic (142). Nevertheless, the extract was more effective in inhibiting 
degranulation when the calcium ionophore was used: the effective concentrations ranged 
between 0.52 mg mL-1 and 2.08 mg mL-1, while in the assay with IgE/antigen the effective 
concentrations varied between 1.04 mg mL-1 and 2.08 mg mL-1, suggesting that the 
compounds present in the extract also affected the increase of cytoplasmic calcium, an 
event that immediately precedes degranulation. 
  A direct effect of organic acids in degranulation could not be established. However, as 
malonic and acetic acids are precursors of fatty acids and also of flavonoids (together with 
shikimic acid), the determination of organic acids was considered important for the 
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characterization of the metabolic profile of this matrix. 
 
In order to clarify whether the effects of the extract were due to the inhibition of 
hexosaminidase release, and not a false positive resulting from the inhibition of β-
hexosaminidase activity, we tested the effect of the extract on β-hexosaminidase activity 
using a basophil cell lysate as source of β-hexosaminidase. As the extract did not inhibit 
β-hexosaminidase enzymatic activity (data not shown), the β-hexosaminidase results 
observed in basophils insulted with an allergic stimulus are due to the extract effects on 
degranulation. 
 
Considering the results obtained with the extract, although the percentage of inhibition 
of degranulation was not very high, it was significantly different from the control, justifying 
the traditional use of bee pollen in allergic diseases. 
 
1.2.3.3. Effect on soybean lipoxygenase activity 
 
Lipoxygenases are enzymes involved in the AA pathway, which catalyze the 
peroxidation of polyunsaturated fatty acids in a selective way. 5-Lipoxygenase 
metabolizes free AA to 5-hydroperoxy-eicosatetraenoic acid (5-HPETE), which is further 
metabolized to leukotrienes. These compounds are pivotal lipid mediators in allergy and 
inflammation (143). Because of structural and functional similarities with mammalian 
enzymes, lipoxygenase obtained from soybean is widely accepted as a model for 
lipoxygenase inhibition studies (144). In this assay, E. plantagineum bee pollen 
hydromethanolic extract was not able to inhibit the activity of this enzyme. As shown in 
section 1.2.2.3., the extract decreased the levels of AA metabolites derived from COX-2 in 
LPS-stimulated macrophages, demonstrating that it has anti-inflammatory activity. As 
during an allergic reaction an inflammatory activity is involved, the extract can contribute 
to ameliorate the symptoms of allergy, through a mechanism not involving the inhibition of 
lipoxygenase. 
 
1.2.4. Antibacterial capacity 
 
In order to evaluate the antimicrobial potential of E. plantagineum bee pollen, the 
hydro- methanol extract was screened against Gram-positive and Gram-negative bacteria.  
Concerning to the effect against Gram-positive bacteria, S. aureus was the only one for 
which it was possible to determine the MIC value (Table 6). The extract also showed 
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some effect against other two Gram-positive bacteria, S. epidermidis and M. luteus, with 
MLC values of 100 and 200 mg mL-1, respectively (Table 6). 
 
Table 6. MIC and MLC values (mg mL-1 pollen) obtained with E. plantagineum bee pollen 
hydromethanol extract against selected bacteria. 
Microorganism MIC MLC 
Gram-positive  
S. aureus         
                            
200                      100 
S. epidermidis 
 
-                          100 
M. luteus 
 
-                          200 
E. faecalis 
 
-                            - 
B. cereus 
 
-                            - 
Gram-negative  
P. mirabillis 
 
-                            - 
E. coli 
 
-                            - 
P. aeruginosa 
 
-                            - 
S. typhimurium 
 
-                            - 
 
Under the tested concentrations, all Gram-negative bacteria were found to be resistant 
to the extract. Previous studies indicated that Gram-negative bacteria appear to be less 
sensitive to the action of several natural extracts (114), which agrees with the results 
above presented. The reason for this may be related with the physical differences 
between the cell walls of Gram-positive and Gram-negative bacteria. The external 
membrane with high content of lipopolysaccharide that surrounds the cell wall in the latter 
is considered to be the major factor contributing to its resistance to chemical stress (115, 
116). 
From the obtained data it can be stated that E. plantagineum bee pollen has low anti-
bacterial activity and only in very high concentrations. As the bee pollen contains organic 
acids, the activity observed might be attributed to these compounds, as they have been 
reported to exhibit general antimicrobial activities and are commonly used as food 
preservatives. Also, it is known that plants synthesize phenolic compounds in response to 
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microbial infection (117) and have shown antimicrobial activity in vitro against a wide 
range of microorganisms. Phenolic activity is concentration-dependent and possibly its 
concentration in the extract was not sufficiently high as to cause a marked bacterial 
inhibition.  
 
2. Acidified methanol extract 
 
2.1. Phenolic composition 
 
In order to study the protective effect of E. plantagineum bee pollen on cells of the 
digestive tract, an acidified methanol extract was prepared. The purpose was to assess 
the effect of each of the two classes of phenolic compounds present in the extract, non-
coloured flavonoids and anthocyanins, and also of the extract as a whole. As 
anthocyanins are positively charged at acidic pH and several authors reported that 
acidified methanol preserves the extracted anthocyanin in their original form, better than in 
a non-acidified solvent system (145), the methanol extract was acidified. The crude 
extract was fractioned by SPE using ethyl acetate and methanol as eluents. Two fractions 
were separated, one enriched in non-coloured flavonoids (fraction I) and the other 
enriched in anthocyanins (fraction II). Twelve phenolic compounds were identified, 
belonging to flavonols (7 compounds) and anthocyanins (5 compounds), as described 
below. 
 
2.1.1. Non-coloured phenolic profile 
 
2.1.1.1. Qualitative analysis 
 
The determined non-coloured phenolic compounds were all derivatives of kaempferol 
(Table 7, Figure 26). Fraction I (eluted with ethyl acetate) contained six compounds, while 
fraction II (collected with methanol, after ethyl acetate elution) and the whole extract 
contained all the identified compounds. In all of the cases the major compound found was 
kaempferol-3-O-neohesperidoside, representing between 73.2% (fraction I) and 75.2% 
(whole extract) of the identified compounds.  
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Figure 26. HPLC-DAD chromatograms of E. plantagineum bee pollen: (A) non-
coloured phenolic compounds in the whole extract (350 nm); (B) anthocyanins in fraction 
II (500 nm). Compounds:  (1) kaempferol-3-O-(4’’-rhamnosyl)-neohesperidoside; (2) 
kaempferol-3-O-sophoroside; (3) kaempferol-3-O-neohesperidoside; (4) kaempferol-3-O-
neohesperidoside-7-O-rhamnoside; (5) kaempferol-3-O-glucoside;  (6+7) kaempferol-3-O-
rutinoside + kaempferol-3-O-(3’’/4’’-acetyl)-neohesperidoside isomer. Compounds: (8) 
delphinidin-3-O-glucoside; (9) delphinidin-3-O-rutinoside; (10) petunidin-3-O-glucoside; 
(11) petunidin-3-O-rutinoside; (12) malvidin-3-O-rutinoside. 
 
2.1.1.2. Quantitative analysis 
 
The total amount of flavonols was 5.6 times higher in fraction I than in fraction II, the 
amount in the whole extract approximately corresponding to the sum of the flavonols 
present in both fractions (6.5 ± 2.0 g kg-1) (Table 7). Fraction I contained higher relative 
amounts of compounds 2, 5 and 6 + 7 than fraction II, while compound 1 was absent. No 
A
U
 
A
U
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statistical differences were found for the relative amounts of compounds 3 and 4 (p>0.05). 
 
Table 7. Non-coloured phenolic compounds in E. plantagineum bee pollen acidified 
methanol extract and fractions (mg Kg -1  pollen)1. 
Compounds Fraction I Fraction II Whole 
1 Kaempferol-3-O-(4’’-rhamnosyl)-
neohesperidoside 
-a 148.27 
± 6.68b 
146.07 
± 23.91b 
2 Kaempferol-3-O-sophoroside 658.49 
± 71.15a 
87.34 
± 10.20b 
635.68 
± 63.57a 
3 Kaempferol-3-O-neohesperidoside 4094.46 
± 49.52a 
735.28 
± 19.08b 
4890.54 
± 118.13c 
4 Kaempferol-3-O-neohesperidoside-
7-O-rhamnoside 
70.16 
± 0.35a,b 
8.31 
± 0.55a 
91.74 
± 1.64b 
5 Kaempferol-3-O-glucoside 395.47 
± 21.83a 
10.82 
± 1.44b 
402.17 
± 3.76a 
6 + 7 Kaempferol-3-O-rutinoside + 
kaempferol-3-O-(3’’/4’’-acetyl)-
neohesperidoside isomer 
373.75 
± 8.53a 
7.40 
± 0.65b 
336.30 
± 14.58a 
Total 5592.33 
± 151.38a 
997.42 
± 31.93b 
6502.50 
± 201.67c 
1 
Values are expressed as mean ± standard deviation of three determinations. Different superscript 
letters in the same row mean statistically significant differences (p<0.05 or higher). 
 
2.1.2. Anthocyanins profile 
 
2.1.2.1. Qualitative analysis 
 
As referred in section 2.2.1. of Introduction, the dark blue colour of E. plantagineum 
bee pollen is attributed to its anthocyanin content (37). Anthocyanins are soluble in polar 
solvents, but are unstable in neutral or alkaline media, being usually extracted from plant 
materials with acidified methanol to prevent alteration of acylated compounds (8). Using 
SPE, a fraction containing almost all the anthocyanins present in the acidified methanol 
extract was obtained by elution with methanol (fraction II), after eluting with ethyl acetate 
to remove some non-coloured phenolic compounds (100). The anthocyanins qualitative 
profile of fraction II can be seen in Figure 26B, being similar to the profile of the whole 
extract (not shown). In order to identify the compounds, an acidic hydrolysis was 
performed and the aglycones obtained were identified by comparison with authentic 
standards. The complete identification of the heterosides present in the extracts was done 
by comparison with standards and bibliography (37). 
 
The chromatogram from fraction II of the acidified methanolic extract showed petunidin-
3-O-rutinoside (11) as the major peak, followed by petunidin-3-O-glucoside (10) (Figure 
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26B). 
 
2.1.2.2. Quantitative analysis 
 
The total amount of anthocyanins was higher in the whole extract than in fraction II. 
Petunidin-3-O-rutinoside (compound 11) was the major compound in both, being the only 
anthocyanin present in fraction I. This compound was found in the whole extract at higher 
quantity than its sum in fractions I and II. Delphinidin-3-O-glucoside and delphinidin-3-O-
rutinoside were present in higher concentration in fraction II than in the whole extract 
(Table 8). Because compound 11 co-eluted with compound 3, the latter being more 
concentrated than the former in the whole extract, the quantification of compound 11 was 
less accurate in the whole extract (though the compounds absorb at different 
wavelengths). The total amount of identified anthocyanins corresponded to 0.313 mg kg-1 
in fraction I, 32.6 mg kg-1 in fraction II and 38.3 mg kg-1 in the whole extract, compound 11 
accounting for 100.0, 74.7 and 77.3% of the total identified anthocyanins, respectively. 
 
Table 8. Coloured phenolic compounds from E. plantagineum bee pollen acidified 
methanol extract and its fractions (mg Kg-1  pollen)1. 
Compounds Fraction I Fraction II Whole 
8 Delphinidin-3-O-glucoside -
a 
1.21 ± 0.05
b 
1.03 ± 0.03
b 
9 Delphinidin-3-O-rutinoside -
a 
0.95 ± 0.06
b 
0.88 ± 0.10
b 
10 Petunidin-3-O-glucoside -
a 
5.41 ± 0.30
b 
5.88 ± 0.48
b 
11 Petunidin-3-O-rutinoside 0.31 ± 0.003
a 
24.30 ± 0.17
b 
29.56 ± 0.58
c 
12 
 
Malvidin-3-O-rutinoside -
a 
0.68 ± 0.02
a,b 
0.92 ± 0.06
b 
Total 0.31 ± 0.003
a 
32.56 ± 0.60
b 
38.26 ± 1.26
c 
1
Values are expressed as mean ± standard deviation of three determinations. Different superscript 
letters in the same row mean statistically significant differences (p<0.05 or higher). 
 
2.2. Biological effects 
 
Protective effects were assessed in Caco-2 cells that mimic the enterocytes of small 
intestine. 
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2.2.1. Cell viability  
 
The effect of E. plantagineum bee pollen acidified methanol extract on the viability of 
Caco-2 cells under quiescent conditions was evaluated by LDH leakage and MTT 
reduction assays (Figure 27). No significant toxicity was observed in the concentrations 
range from 0.31 to 20.0 mg mL-1 for fractions I and II. However, at the higher 
concentrations tested, the whole extract caused a significant decrease in cellular viability, 
as assessed by the MTT assay (p<0.0001, n=5). This loss of cellular viability cannot be 
attributed to one class of phenolic compounds, since neither fraction I (nearly free of 
anthocyanins), nor fraction II (containing 15% of total flavonols and anthocyanins), caused 
a significant decrease of cell viability at this concentration. Rather the combined effects of 
anthocyanins with high amounts of flavonols may be responsible for the observed toxicity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Viability of Caco-2 cells evaluated by LDH and MTT assays. Cells were treated 
with E. plantagineum bee pollen acidified methanol extract and fractions for 24 h, or were 
pre-treated for 24 h with E. plantagineum bee pollen acidified methanol extract and 
fractions followed by 6 h treatment with 150 µM of t-BHP (without extract co-incubation). 
Results are presented as mean ± standard error of the mean of five independent 
experiments performed in triplicate. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
compared to the respective control (with or without t-BHP). 
 
Flavonoids can act as antioxidants in their reduced form but, when oxidized to 
phenoxyl radicals or quinone/quinone methide intermediates, they can have pro-oxidant 
activities (146). A pro-oxidant effect has been described for both classes of flavonoids 
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present in E. plantagineum bee pollen. Flavonol compounds with a phenolic B ring like the 
kaempferol derivatives found in the extracts may act as pro-oxidants after oxidation by 
peroxidases/H2O2 to phenoxyl radicals, accompanied by GSH co-oxidation and oxygen 
activation, resulting in superoxide radical and H2O2 formation (147). Also, a pro-oxidant 
effect of anthocyanidins in HL-60 cells was attributed to intracellular hydrogen peroxide 
production, triggering an apoptotic death program through oxidative stress (148). This 
may explain why only in the MTT assay a significant loss of viability was observed. 
Oxidative stress can be induced in cells by t-BHP, which is metabolized by Cyt P450, 
leading to the formation of toxic peroxyl and alkoxyl radicals that initiate lipid peroxidation, 
affect cell integrity and form covalent bonds with cellular molecules, resulting in cell death 
(149, 150). The exposition of Caco-2 cells to 150 µM t-BHP for 6 h lead to a reduction of 
viability to 79.3 ± 3.2 % of control in LDH leakage assay (p<0.0001, n = 5) and 63.0 ± 0.3 
% in the MTT assay (p<0.001; n = 5). The higher sensitivity of MTT assay in detecting t-
BHP toxicity can be explained by the fact that its biotransformation by Cyt P450 and GPx 
occurs mainly in the mitochondria (149, 151, 152). The pre-treatment of Caco-2 cells with 
the extracts did not prevented, nor aggravated, the toxicity of t-BHP, as measured by the 
LDH leakage assay (Figure 27). However, the extracts containing anthocyanins (fraction 
II and the whole extract) significantly aggravated t-BHP toxicity, as measured by the MTT 
assay, fraction II being more deleterious (Figure 27). When the cells were pre-treated with 
this fraction, a significant increase of cell death (compared to the control with t-BHP) was 
observed for extract concentrations higher than 1.25 mg mL-1 (p<0.0001, n=5), while with 
the whole extract the differences in cellular viability were only seen between 2.5 and 10 
mg mL-1 (p<0.001 or higher, n=5). The additional cellular death, observed only in the MTT 
assay, may be a consequence of the depletion of cellular defences of cells pre-exposed to 
anthocyanins, due to their ability to induce the production of reactive species (148). 
On the other hand, fraction I showed a tendency to protect Caco-2 cells from t-BHP-
induced toxicity, directly dependent on its concentration, although the differences of 
cellular viability were not statistically significant (Figure 27). The viability of cells pre-
treated with faction I at the concentration of 20 mg mL-1 was increased to 84.7 ± 16.3% of 
control, as measured by the MTT assay. Also, the pre-exposition to the whole extract at 
20.0 mg mL-1 did not increased cellular death assessed by the MTT assay (p>0.05, n=5), 
which was nearly the same has in the cells exposed to t-BHP only, although at this 
concentration the whole extract induced cellular death by itself (Figure 27). It can be 
assumed that, in insulted cells, the pre-exposition to flavonols may stimulate antioxidant 
defences, which help fighting the subsequent oxidative stress induced by t-BHP. 
Probably, the pro-oxidant effects of anthocyanins do not prepare the cells for a 
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subsequent insult, resulting in increased toxicity. As observed in the assay with the whole 
extract at 20 mg mL-1, this toxicity can be counteracted by the defences induced by 
flavonols, although they contribute to the overall oxidative stress observed in cells 
exposed to the extract.  
 
The effects of E. plantagineum bee pollen in cellular viability greatly depend upon the 
cell line. In fact, as shown above, the hydromethanol extract of this material caused loss 
of macrophages viability at concentrations higher than 30 mg mL-1 (Figure 19), but 
basophils revealed decreased viability at 8 mg mL-1 (section 1.2.3.1.). Since macrophages 
are known to produce reactive species (153) and the gastrointestinal tract is constantly 
exposed to reactive oxygen, chlorine, and nitrogen species (154), the sensitivity of the 
different cells lines can be explained by the oxidative stress induced by extract 
compounds and cellular ability to oppose to it.  
 
2.2.2. Reactive species 
 
The levels of reactive species were measured by the DCFA-DA assay. The exposure 
of Caco-2 cells to 150 µM t-BHP lead to a significant increase of reactive species to 126.5 
± 1.4% of control after 30 min (p<0.0001, n = 5), reaching a maximum of 133.7 ± 1.8% 
after 150 min, and decreasing to 130.1 ± 2.9% after 240 min. Fraction I significantly 
decreased the levels of reactive species in a concentration and time dependent manner, 
this ability being reduced over time (Figure 28). The lower concentrations of fraction I and 
of the other extracts were more effective in reducing reactive species (Figure 28). For 
instance, pre-exposure to 1.25 mg mL-1 of fraction I reduced the level of reactive species 
induced by t-BHP to 111.6 ± 3.6% after 30 min (p<0.01), but after 240 min the level of 
reactive species achieved was 116.6 ± 4.2% (p<0.05). On the other hand, the levels of 
reactive species were 122.4 ± 2.0% (p>0.05) after 30 min and 137.7 ± 5.4% (p>0-1.05) 
after 240 min, when the cells were pre-exposed to the extract at 20 mg mL-1.  
In cells pre-exposed to fraction II a more pronounced effect on the levels of reactive 
species induced by t-BHP was observed (Figure 28). Excepting 20 mg mL-1, all 
concentrations lead to a significant decrease in the levels of reactive species during the 
240 min evaluation period (p<0.01 or higher). It should be noted that the levels of reactive 
species were reduced to the levels attained in cells not exposed to t-BHP when the cells 
were pre-exposed to 1.25 mg mL-1 of fraction II (100.6 ± 4.5% after 30 min and 99.1 ± 
3.8% after 240 min exposition to t-BHP). Although no statistical difference was seen for 
the concentration of 20 mg mL-1, the levels of reactive species were lower than in cells not 
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pre-treated with extract (116.9 ± 3.5 mg mL-1 after 30 min and 129.0 ± 3.7 mg mL-1 after 
240 min). 
Surprisingly, the whole extract, containing the compounds of both fractions, not only 
was unable to reduce the levels of reactive species induced by t-BHP, but further 
aggravated the oxidative stress after 180 min in cells pre-exposed to 20 mg mL-1 of the 
extract (Figure 28). At this concentration, the levels of reactive species reached 152.4 ± 
5.9% after 240 min exposition to t-BHP (p<0.0001). However, at the beginning of the 
measurements they were of 115.2 ± 3.6% (p>0.05), and for lower concentrations no 
statistical differences were seen (116.8 ± 1.5% after 30 min and 126.7 ± 1.7% after 240 
min in cells pre-exposed to 1.25 mg mL-1 of whole extract). The whole extract was the one 
with higher variations in the levels of reactive species measured over time, being this 
effect detected earlier with higher concentrations. It showed a tendency to increase the 
levels of reactive species over time, with statistical differences being noticed, from the 
concentration of 2.5 mg mL-1, while with the other extracts a significant increase was only 
seen at 20 mg mL-1 for fraction II and 10 mg mL-1 for fraction I.  
Although the levels of reactive species were measured without taking into account the 
viability of cells, a significant decrease in this parameter measured by the MTT assay was 
seen after 6 h exposure to t-BHP in cells pre-exposed to concentrations from 2.5 mg mL-1 
of fraction II and from 2.5 to 10 mg mL-1 of the whole extract (Figure 28). So, the results 
may reflect the levels of reactive species in viable and unviable cells. 
Fraction II, which showed the higher ability to aggravate the toxicity induced by t-BHP, 
was the one that reduced the levels of reactive species more pronouncedly (Figure 28). It 
is possible that reactive species produced during the pre-exposition to anthocyanins and 
other compounds present in fraction II have inactivated Cyt P450, diminishing in this way 
the biotransformation of t-BHP and, consequently, the levels of reactive species. The 
inhibition of the activity of several Cyt P450 isoforms by anthocyanins has already been 
described (155, 156). For instance, petunidin inhibited Cyt P450 3A4 activity with an IC50 
of 23 µM (155). Flavonols (present in both fractions, as well as in the whole extract) may 
also contribute to the inhibitory activity of these enzymes (157). The viability of cells pre-
exposed to higher concentrations of fraction II was adversely affected, as seen by the 
MTT assay (Figure 27), and the levels of reactive species induced by t-BHP were higher 
than in cells exposed to lower extract concentrations (Figure 28). It is possible that when 
cells with lower Cyt P450 activity were exposed to t-BHP, new radical species were 
generated by non-enzymatic reaction of t-BHP with iron, as demonstrated by Castilho and 
collaborators in an experiment using the iron chelator o-phenantroline with diminished 
toxicity of t-BHP (158). This fact may also explain the increased toxicity observed with the 
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whole extract, which can be due to the combined effects of anthocyanins and high 
amounts of flavonols in Cyt P450 inhibition. 
In addition to Cyt P450 inhibition, the antioxidant ability of fractions I and II seen in this 
assay can be attributed to direct scavenging effect or metal chelating properties of the 
flavonoids absorbed by the cells previously to t-BHP exposure (159, 160).  
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Figure 28. Reactive species in Caco-2 cells exposed to 150 µM t-BHP after pre-treatment 
with E. plantagineum bee pollen acidified methanol extract and fractions for 24 h. Results 
are presented as mean ± standard error of the mean of five independent experiments. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 compared to the control (with t-BHP). 
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2.2.3. Glutathione homeostasis 
 
The involvement of GSH in t-BHP detoxification is well known (161). t-BHP acts as a 
substrate for cytosolic glutathione peroxidases, causing the oxidation of GSH to 
glutathione disulphide (GSSG). The activity of GR operating at the expense of NADPH 
and the release of GSSG into the extracellular medium maintains a steady state in 
intracellular levels of GSH (162). In this work, the levels of glutathione (reduced + 
oxidized; GSHt) were of 22.88 ± 1.72 nmol mg-1 protein in quiescent cells and significantly 
increased to 42.84 ± 3.12 nmol mg-1 protein after 6 h exposure to 150 µM t-BHP (p<0.01, 
n=5). A further increase of GSHt levels was observed in cells previously exposed to 20 mg 
mL-1 of the whole extract (p<0.05, n=5) (Figure 29). It has been reported that the 
exposure of isolated hepatocytes to t-BHP leads to a rapid decrease of intracellular GSH 
levels (150, 163). However, similarly to the results found in this work, in Caco-2 cells an 
increase in GSH levels exposed to t-BHP has been already observed (164). The results 
may suggest an attempt of the cells to overcome the induced oxidative stress, by 
increasing GSH, the main antioxidant involved in t-BHP detoxification (161). 
 
 
 
 
 
 
 
 
 
 
Figure 29. Glutathione levels in Caco-2 cells treated with E. plantagineum bee pollen 
acidified methanol extract and fractions for 24 h, or pre-treated for 24 h with E. 
plantagineum bee pollen acidified methanol extract and fractions followed by 6 h 
treatment with 150 µM of t-BHP (without extract co-incubation). Results are presented as 
mean ± standard error of the mean of five independent experiments. *p<0.05, compared 
to the respective control. 
 
The increase of GSHt with the higher concentration of the whole extract (and less 
significantly with the higher concentration of fraction II and with 5 mg mL-1 of fraction I) 
may justify an inversion in the tendency of the extracts to aggravate the deleterious effects 
of t-BHP, although not accompanied by a significant reduction of the levels of reactive 
species seen with lower extract concentrations (Figure 30). The balance between 
antioxidant and pro-oxidant effects of the compounds present in the extract and fractions 
may justify their dual behaviour. It should be noted that the effects of flavonoids are not 
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limited to antioxidant or pro-oxidant mechanisms, since these compounds can interfere 
with many cellular molecules and processes (8, 146). 
 
Under the assay conditions it was not possible to determine the intracellular levels of 
GSSG (below 0.38 nmol mg-1 protein). The low levels of GSSG (less than 1% of GSHt) 
can be explained by both its reduction to GSH by GR and its efflux from the cell (162). 
 
2.2.4. Antioxidant enzymes 
 
Since t-BHP detoxification involves its reduction by glutathione peroxidase (GPx) with 
concomitant oxidation of GSH to GSSG (162), an attempt was made to quantify GPx and 
GR, the later implicated in the recycling of GSSG back to GSH. Under the assay 
conditions, the activity of GPx was below the detection limit of the method (p<0.02 U mg-1 
protein). GR activity in cells exposed to the extract or fractions for 24 h was not 
statistically different from control (0.027 ± 0.001 U mg-1 protein) at the concentrations 
tested (p>0.05; n=5).  
 
Mitochondrial GSH transferases (GST) may prevent lipid peroxidation in mitochondria 
by a non-selenium glutathione-dependent peroxidase activity. Because t-BHP is a known 
substrate for GST, the activity of this enzyme was determined, being of 0.101 ± 0.006 U 
mg-1 protein in control cells. GST activity in cells exposed to the extracts was not 
statistically different from the control (p>0.05; n=5). However, the non-coloured phenolic 
fraction showed a tendency to decrease GST activity, reaching 0.089 ± 0.006 U mg-1 
protein at the concentration of 20 mg mL-1. 
Although t-BHP does not react with catalase (165), the activity of this enzyme and of 
SOD was evaluated, due to their importance in the detoxification of H2O2 and superoxide 
that can be produced by a pro-oxidant effect of flavonoids, including flavonols and 
anthocyanins (147, 148), and in the maintenance of the redox cellular status, in general. 
Catalase activity in control was 7.444 ± 1.012 U mg-1 protein. When the cells were 
exposed to E. plantagineum bee pollen extract or fractions the enzyme activity varied 
between 5.998 ± 0.647 and 6.839 ± 0.829 U mg-1 protein. No statistical differences were 
seen for catalase activity (p>0.05; n = 5).  
The extracellular SOD is a copper-zinc isoform of SOD that contains a signal peptide 
that directs this isoform exclusively to extracellular spaces (166). The activity of this 
enzyme in control was 0.100 ± 0.009 U mg-1 protein. Because the extracts exert a direct 
activity on superoxide, it was not possible to distinguish between the effects on SOD 
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activity and the superoxide scavenging activity of the extracts. For this reason an assay 
was performed using the extract and fractions incubated in culture medium, under the 
same conditions used to evaluate SOD activity, but without cells.  
The results obtained for the variation of superoxide with or without the cells are 
presented in Figure 30. Fraction I was able to decrease superoxide levels, but this ability 
was higher in the cell-free assay, indicating a scavenging activity rather than induction of 
extracellular SOD. Significant differences from the control were observed from 2.5 mg mL-
1 (p<0.01; n=4) in the cell-free assay, and from 10 mg mL-1 (p<0.05, n=5) in the assay with 
cells. Comparing the two assays (with and without cells), they were significantly different 
from 5.0 mg mL-1 (p<0.0001). This result can be explained by the inhibition of extracellular 
SOD, but, it is possible that some compounds were absorbed or modified by the cells, and 
were not available for superoxide scavenging. Considering fraction II and the whole 
extract, they exerted a slight scavenging activity (not statistically significant) for 
concentrations up to 5 mg mL-1 in the cell-free assay. This tendency was not observed in 
the assay with cells. At the concentration of 20 mg mL-1 a pro-oxidant effect was observed 
in both assays, although it was statistically significant only with fraction II in the assay with 
cells (p<0.001). 
The ability of fraction I to scavenge superoxide radicals may contribute to the tendency 
of this extract to protect Caco-2 cells from t-BHP induced toxicity (Figures 28 and 30). 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 30. Effect of E. plantagineum bee pollen acidified methanol extract and fractions in superoxide levels. Superoxide was generated by the 
PMS/NADH system, and monitored by the reduction of NBT, in the presence of the extracts dissolved in culture medium and previously 
incubated for 24 h in a CO2 incubator at 37 °C either with or without cells. Results are presented as mean ± standard error of the mean of four 
(without cells) or five (with cells) independent experiments. 
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Conclusions 
 
The work presented in this dissertation provides an increased knowledge of the chemical 
profile and the biological potential of E. plantagineum bee pollen. 
The main conclusions are listed below. 
 
Hydromethanol extract: 
 Significant amounts of phenolic compounds were found. 
 Eight organic acids and five fatty acids were determined for the first time. 
 In vitro assays revealed the ability to scavenge NO and O2
-, although for the latter a 
pro-oxidant behaviour was observed for the higher concentrations tested. 
 The extract reduces NO and prostaglandins release in LPS-stimulated macrophages, 
but, in what concerns to prostaglandins, this is true only if the extract concentrations are 
maintained below certain levels. 
 The levels of prostaglandins metabolites derived from Cyt P450 enzymes, like 20-
hydroxy-PGE2 and 6-keto-PGF1α, are reduced by high extract concentrations. However, 
under those conditions several isoprostanes are increased. 
 The extract is effective in inhibiting basophils degranulation under an allergic 
stimulus, as ascertained by the levels of β-hexosaminidase released. Nevertheless, some 
deleterious effects on insulted cells were noticed at the highest tested concentrations.
 Reduced antibacterial capacity was observed and just against S. aureus, S. 
epidermidis and M. luteus.

Acidified methanol extract and fractions: 
 Seven flavonols and five anthocyanins were determined. 
 The phenolic extracts were not efficient at protecting Caco-2 cells from the oxidative 
stress induced by t-BHP, although the removal of anthocyanins ceased the pro-oxidant 
effects and imparted a small protection. 
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 The antioxidant potential of the compounds may be abrogated by the fact that in the 
presence of iron t-BHP generates reactive species, which can be more deleterious than the 
ones generated by its biotransformation. 
 The pro-oxidant effects seen with the extracts containing anthocyanins may also be 
ascribed to their ease in being themselves converted into radical species. 
 The protective effects seem to be related with the levels of total glutathione. 
 
 
Overall, the results obtained demonstrate that E. plantagineum bee pollen bioactive 
compounds can impart beneficial health effects, by reducing the levels of oxidative stress 
and inflammatory mediators involved in the genesis of many diseases, and also by 
preventing allergy and ameliorating allergy symptoms. 
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